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Abstract 
  
 
 In the latter stages of gestation the fetal lung undergoes biochemical 
maturation leading to the acquisition of the capacity to synthesize pulmonary surfactant. 
If insufficient amounts of surfactant are generated neonatal respiratory distress 
syndrome (NRDS) is likely to occur. The production of surfactant is known to involve a 
cellular communication between lung fibroblasts and the adjacent type II pneumocytes. 
Glucocorticoids have been shown to induce the production by lung fibroblasts of a 
soluble peptide, fibroblast-pneumocyte factor (FPF), which in turn acts on type II 
pneumocytes to enhance the synthesis of surfactant (Smith, 1978). Although Torday et 
al. (2002) have proposed that leptin has many of the characteristics of FPF, recent 
research has revealed that the peptide neuregulin-1β also has many of these 
characteristics (Dammann et al., 2003). ` 
 Neuregulin was first purified from brain tissue and named glial growth 
factor (Brockes et al., 1980). Subsequently, it was established that the neuregulins are a 
family of EGF-like growth factors that have been shown to be present in an increasing 
number of tissues and organisms. Neuregulin-1β stimulates both cell growth and 
differentiation in a range of target tissues by binding to ErbB3 and ErbB4 receptors thus 
stimulating the phosphorylation of tyrosine residues of the ErbB receptors and   
inducing receptor heterodimerization (Riese et al., 1995; Carraway III et al., 1997; 
Crovello et al., 1998; Mautino et al., 2004). 
 iv 
 
 In this study, a commercially available form of neuregulin-1β (heregulin-1β) 
has been shown to directly stimulate synthesis of surfactant phospholipids in cultured 
fetal rat type II pneumocytes. Prior exposure of the type II cells to 20-50 ng.mL
-1
 
heregulin-1β for 21 hours led to a more than 3-fold increase in the rate of phospholipid 
synthesis (p < 0.05), a result similar to that previously observed in cells exposed to 
leptin (Torday et al., 2002). In addition to this effect, 50 ng.mL
-1 
heregulin-1β was also 
shown to directly increase the rate of secretion of surfactant phospholipids from type II 
cells by 2.4-fold (p < 0.05). Furthermore, exposure of type II cells to this peptide 
enhances by approximately 2-fold the β-AR activity and, as a consequence, elevates the 
rate of (—)-isoproterenol-induced surfactant phospholipid secretion to the same extent. 
Although heregulin-1β alone has no effect on β-AR gene expression in type II cells, the 
level of expression of this gene was synergistically enhanced when the cells were 
exposed to both dexamethasone and this peptide. Thus, overall, these findings not only 
support but considerably extend the concept promoted by Dammann et al. (2003) that 
neuregulin-1β plays an essential role in the differentiation and maturation of the lung in 
the later stages of gestation. Moreover, they suggest that neuregulin-1β is a significant 
component of FPF.   
 In summary, this study has shown that in type II cells neuregulin-1β 
enhances both surfactant phospholipid synthesis and secretion, elevates the level of 
β-adrenergic receptors and boosts the response of both male- and female- derived cells 
to β-agonists. It is therefore suggested that the administration of neuregulin-1β, in 
combination with antenatal glucocorticoid treatment, may provide an improved 
therapeutic mechanism of preventing respiratory distress syndrome of premature 
infants.   
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1.1 General introduction    
 The alveolar surfaces of the lungs are lined with a heterogeneous material 
called pulmonary surfactant, which forms a monolayer on the internal surface of the 
alveoli. The main role of surfactant is to reduce the surface tension at the air: liquid 
interface. This prevents alveolar collapse at low pressures and allows the lung to remain 
filled with air even after expiration. The functional properties of surfactant are provided 
by its phospholipids and proteins, both of which are necessary for establishing and 
maintaining a low surface tension. Since the lungs are not involved in gas exchange 
until after birth, it is not surprising that surfactant is only formed in the later stages of 
development. Premature delivery of infants is often accompanied with lung immaturity, 
resulting in a deficiency of surfactant (Clements and Avery, 1998; Avery, 2000). This 
phenomenon leads to neonatal respiratory distress syndrome (NRDS), a condition that, 
if untreated, can be fatal.  
Throughout gestation, the human fetal lung develops within its fluid 
intrauterine surroundings, but must adjust to the extra-uterine environment at birth. 
There are many physiological processes that must take place to allow this adjustment, 
and key among them is the induction of pulmonary surfactant. Pulmonary surfactant is a 
complex, surface-active material that contains phospholipids and the surfactant-
associated proteins SP-A, SP-B, SP-C, and SP-D. Surfactant is known to generate a 
monolayer lining at the air: liquid interface of the lung (Griese, 1999) (Figure 1.1). 
The air: liquid interface within the alveoli is subjected to large variations in 
the surface tension which, if unmodified, would lead to progressive atelectasis and 
ultimately respiratory collapse (Griese, 1999). The primary function of pulmonary 
surfactant  is  to  reduce  this surface tension  to very low values, and dynamically adjust  
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Figure 1.1 Diagrammatic representation the alveolar space with the 
air: liquid interface magnified to illustrate the surfactant 
monolayer (Whitsett and Weaver, 2002). 
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the tension as the surface area changes with each inspiration and expiration (Johannson 
and Curstedt, 1997). Surfactant also functions to protect the lung from injury and 
infection  that may be caused by the inhalation of particles and microorganisms (Griese, 
1999). 
1.2 Lung maturation 
Lung epithelial cell differentiation is dependent upon a mesenchymal-
epithelial cell communication. The fetal lung undergoes an extensive morphological and 
biochemical maturation during late gestation to enable it to be capable of gas exchange. 
For example, there is a dramatic increase in the production of the highly surface-active 
substance known as pulmonary surfactant. Its main functional component is disaturated 
phosphatidylcholine (DSPC), which lowers surface tension and prevents alveolar 
collapse (Buckingham and Avery, 1962). Differentiation of the respiratory epithelial 
cells lining the lung increases in the later stages of lung morphogenesis. Lung 
maturation is associated with (i) the generation of lung saccules and the formation of 
septae to produce alveoli, (ii) synthesis and secretion of pulmonary surfactant required 
to reduce surface tension at the air: liquid interface after birth, (iii) clearance of lung 
fluids after birth, (iv) thinning of the alveolar walls, and (v) the development of the 
pulmonary vascular bed to facilitate the process of gas exchange across the alveolar 
capillary barrier (Besnard et al., 2011).  
1.3  History of the surfactant system 
Research on surfactant began in the mid 20
th
 century when Thannhauser et 
al. (1946) reported that lung tissue has an extraordinarily high content of the lipid 
dipalmitoyl lecithin (currently termed dipalmitoyl phosphatidylcholine). At that time, no 
connection was made between the high content of this lipid and stabilization of the 
alveoli. Nine years later, Pattle proposed that bubbles, made of a lung fluid substance, 
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obtained their steadiness through the quantity and quality of the surface-active material 
(Pattle, 1955). 
 Clements et al. (1958) showed, with the help of a modified surface balance, 
that  surface tension dropped to low values upon compression of surface films generated 
using lung extracts. Clements and his group were also the first to investigate the surface 
tension-lowering properties of several lipid fractions and found that it was the 
phospholipid fraction that reduced surface tension. This effect was repressed by other 
lipid fractions (cholesterol, triacylglycerols, and fatty acids). Subsequently, it was 
reported that the activity of synthetic dipalmitoyl phosphatidylcholine (DPPC) was 
similar to that of the phospholipids isolated from fresh beef lung (Klaus et al., 1961). 
Later it was shown that DPPC was produced by the developing lung and secreted into 
the alveolar space (Gluck et al., 1967). Hallman and co-workers discovered the 
importance of phosphatidylglycerol (PG) in contributing to surfactant spreading and 
that children suffering from respiratory distress syndrome had diminished levels of this 
phospholipid (Hallman et al., 1977). Even though PG contributes only 5-7% of the total 
weight of purified surfactant, it is highly enriched relative to its content in mammalian 
membranes and, in conjunction with surfactant proteins SP-A and SP-B, appears to be 
important in the formation of tubular myelin (Wright, 1997).   
 It was subsequently documented that lipid extracts alone were not sufficient 
to reduce surface tension and attention focused on the presence and role of the proteins 
in surfactant (King et al., 1973). This resulted in a rapid expansion of research into the 
molecular biology, structure, and properties of pulmonary surfactant proteins. In 1989 a 
new nomenclature for surfactant proteins was proposed. The proteins were termed 
surfactant protein A, B, and C and subsequently a new protein, termed SP-D was added 
(Persson et al., 1989) . 
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 Although our understanding of the composition of surfactant and the 
structure of surfactant proteins has advanced greatly, the various functions of the 
surfactant proteins remain only partially understood. Nonetheless, artificial surfactants 
that include surfactant proteins have been used to treat neonates weighing 500-1500 g 
and suffering from respiratory distress syndrome. In a comparative study, infants were 
divided into two groups according to whether they were born before or after these 
surfactants were introduced into clinical practice. Regression models controlling for 
race, sex, and birth weight were used to assess the incidence of mortality. The odds of 
death for very low birth weight infants were shown to be reduced by 30 percent after 
exogenous surfactants were introduced (Schwartz et al., 1994). 
1.4 Anatomical aspects of the lung 
The lung is a large organ (6 percent of the body volume, irrespective of 
body weight) with a large inner surface continuously in contact with the environment. 
Mammalian lungs are membranous sacs divided into alveoli, which are small sacs that 
vastly increase the surface area available for gas exchange. An analysis of the human 
lung indicates that 1 cm
3
 of lung tissue has a total gas exchange surface of 300 cm
2
. 
Because warm-blooded animals require a high rate of oxygen uptake, the large surface 
area is essential (Creuwels et al., 1997). Although some gas exchange takes place in the 
terminal conducting airways, the alveoli are the principle site in which gas exchange 
occurs (Swenson et al., 1992). The alveoli are bubble-shaped with a high curvature and 
are known to be the site where both oxygen and carbon dioxide diffuse across the 
capillary/alveoli interface (Bock et al., 1929; Campbell, 1931). 
The lung contains many different cell types (Copenhaver and Johnson, 
1958; Brown and Longmore, 1981) but the production of pulmonary surfactant is 
regulated by the interaction between only two of these - epithelial type II pneumocytes 
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and mesenchymal fibroblasts (Smith, 1979). Smith found that a peptide, which he 
termed fibroblast-pneumocyte factor (FPF), is produced by the fetal lung fibroblasts in 
response to glucocorticoids. When fetal rats were injected on day 17 of gestation with 1 
µg of this material, the rats showed on day 20, biochemical evidence of accelerated lung 
maturation when compared to littermate controls (Smith, 1979). Epithelial type II 
pneumocytes represent about 14.5% of the cell population of the lung parenchyma 
(Haies et al., 1980). A feature of these cells is the presence of surfactant storage 
organelles called lamellar bodies that are surrounded by a limiting membrane and which 
fuse with the plasma membrane to allow secretion of their contents (Haagsman and Van 
Golde, 1991; Andreeva et al., 2007). Type II cells synthesize surfactant components, 
which are then stored in the lamellar bodies until the appropriate stimuli trigger their 
contents to be secreted into the alveolar airspace. King and his coworkers reported that 
the contents of the lamellar bodies enlarge and upon secretion undergo complex 
alterations including formation of a lattice-like structure called tubular myelin (Wright, 
1990). This process is triggered by calcium, as well as the environmental conditions 
within the alveolar space (King et al., 1983; Schmitz and Muller, 1991).  
Differentiation of type II pneumocytes is triggered by the subjacent 
mesenchyme (fibroblasts). Fibroblasts from the pseudo-glandular stage stimulate 
epithelial cell proliferation, whilst those from the saccular stage stimulate differentiation 
(Caniggia et al., 1991). In addition, fibroblasts in close proximity to the epithelial cells 
produce mainly differentiation factors whilst those further away produce mainly 
proliferation factors (Deimling et al., 2007). Pneumocyte cells do not respond to 
proliferation factors once they have developed beyond the saccular stage (Caniggia et 
al., 1991). In the later stages of development the fibroblasts respond to glucocorticoids 
and secrete differentiation factors (Smith, 1979; Caniggia et al., 1991). Glucocorticoids 
have been shown to bind more readily to fibroblasts adjacent to type II pneumocytes 
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than to those more distantly located, a consequence of the adjacent fibroblasts being 
enriched with glucocorticoid receptors (Caniggia et al., 1991). A central role for 
glucocorticoids in lung differentiation and maturation has been demonstrated in 
corticotropin-releasing hormone-deficient mice, which die from respiratory 
insufficiency due to abnormal lung development, a result of reduced levels of 
glucocorticoids (Muglia et al., 1995; Muglia et al., 1999).         
The use of whole lungs in studying cellular differentiation does not take into 
consideration the cellular variety found within lungs nor the contribution of the 
individual cell types (Douglas and Farrell, 1976; Dobbs, 1990). Post and his co-workers 
found that cultured fetal alveolar type II pneumocytes retain many of the characteristics 
of those cells in vivo, particularly their ability to synthesize and secrete 
phosphatidylcholine (PC). Cultured type II cells also retain the ability to proliferate and 
respond to fibroblast-pneumocyte factor (FPF) (Post et al., 1984; Post and Smith, 1984). 
Several factors increase the quality of type II cell cultures: (i) when collagenase is used 
as the tissue disassociating agent the cultured cells have a higher purity, and (ii) the 
growth of these cells is optimised if the media is supplemented with fetal calf serum 
(Douglas and Farrell, 1976).  
1.5 Components of pulmonary surfactant  
The physiological value of surfactant was first recognised in premature 
infants with respiratory distress syndrome (also known as hyaline membrane disease) 
(Stefansson et al., 2002), a condition which can now be  treated by intra-amniotic 
administration of pulmonary surfactant (Zhang et al., 2004). A range of other lung 
diseases are also associated with surfactant abnormalities (Griese, 1999). The latter 
author reported that pulmonary surfactant is a highly surface-active material consisting 
of both lipids and specific surfactant-associated proteins. Lung surfactant is synthesized 
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by epithelial type II pneumocytes and its component lipids and hydrophobic proteins 
(SP-B and SP-C) are stored in lamellar bodies and secreted by regulated exocytosis 
(Rooney, 2001).  Surfactant plays a vital role in pulmonary physiology. It has the major 
biophysical function of preventing alveolar collapse and thus neonatal respiratory 
distress syndrome (Holm et al., 1996; Johannson and Curstedt, 1997; Mallory Jr, 2001). 
 Biochemically, pulmonary surfactant is nearly nine-tenths lipids, comprising 
phospholipids, triglycerides, cholesterol and fatty acids (King, 1982; Johannson and 
Curstedt, 1997; Lang et al., 2005), and phosphatidylglycerol (PG) (Rooney et al., 1994). 
The majority of the pulmonary surfactant lipids are phospholipids and the most 
abundant phospholipid is phosphatidylcholine (PC). The PC component is largely 
disaturated phosphatidylcholine (DSPC), consisting mostly of dipalmitoyl 
phosphatidylcholine and palmitoyl-myristoyl phosphatidylcholine, and plays an 
essential role in decreasing surface tension (Bernhard et al., 2011). Pulmonary 
surfactant also contains a relatively large portion of phosphatidylglycerol (PG) (Griese, 
1999; Bernhard et al., 2011). Studies on PG-deficient adult rabbits have shown no 
obvious changes to surfactant properties or function, although these studies did use 
phosphatidylinositol (PI) as a substitute for PG (Hallman et al., 1985).  Human infants 
born prior to the pre-natal increase in PG levels are more likely to suffer from  
respiratory distress than infants born after the increase (Hallman et al., 1977), 
suggesting a definite role for phosphatidylglycerol in the function of surfactant. It is 
possible that the presence of phosphatidylglycerol helps with alveolar strength (Hallman 
and Gluck, 1976), or with the association of proteins with phospholipids (King and 
Martin, 1980).  
 Surfactant generally contains between 5-10% of protein (Figure 1.2). 
Surfactant-associated proteins (SP) are known to interact extensively with the 
phospholipids, including  changing  the  structure  and  properties of the lipid layers and  
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Figure 1.2  The composition of pulmonary surfactant expressed as a 
percentage by weight (Smith, 1979; King, 1982). 
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films (Yu and Possmayer, 1988; Dhand et al., 1998). There are four surfactant proteins 
that have been identified: SP-A, SP-B, SP-C and SP-D. The general characteristics of 
each protein are summarized in Table 1.1. 
Recent research has shown that the formation and stability of surfactant is 
highly dependent on surfactant protein B and C (Weaver and Conkright, 2001), while 
SP-A and SP-D are important components of the innate immune response to microbial 
challenge and participate in other aspects of immune and inflammatory regulation 
within the lung (Crouch and Wright, 2001). Type II pneumocytes secrete these proteins 
after exposure to leptin, which is produced and secreted by lung lipo-fibroblasts (Torday 
et al., 2002). Leptin induces an increase in fetal lung weight in relation to the body 
weight due to an increase in the number of type II pneumocytes, which are responsible 
for producing SP-A, SP-B and SP-C proteins (Kirwin et al., 2006).  Thus, leptin appears 
to be a key cytokine regulator of fetal lung maturation. Other proteins have also been 
isolated with surfactant, including albumin and immunoglobulin, however, these may be 
contaminates that arise during tissue processing (King et al., 1973).  Chailley-Hey and 
her co workers (1999) found that vitamin A deficiency delays fetal lung maturation by 
reducing the expression of the gene for fatty acid synthesis. A deficiency of this vitamin 
also reduces the amount of mRNA coding for surfactant proteins A, B and C. 
 The most abundant surfactant protein by weight is SP-A. The SP-A 
monomer (molecular weight 26-36 kDa) is a glycoprotein with three separate structural 
domains (Johannson and Curstedt, 1997; Crouch, 1998). A collagen-like domain is 
connected via a linking region (a possible binding site for phospholipids) to a globular 
region, which contains a calcium-dependent carbohydrate recognition domain (CRD) 
that  is  able to bind both  lipids, type II pneumocytes, and  other structures, such  as  the  
 
Chapter 1  Introduction 
11 
 
 
Table 1.1 Characteristics of the four surfactant-associated proteins, SP-A, 
SP-B, SP-C and SP-D (Yu and Possmayer, 1988). 
 
Protein Size Structure MW of polypeptide  
(kDa) 
Polarity 
SP-A High Octadecamer 26.0-36.0 Hydrophilic 
SP-B Low Dimer 8.7 Hydrophobic 
SP-C Low Monomer 3.5-5.0 Hydrophobic 
SP-D High Dodecamer 39.0 Hydrophilic 
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surface of microorganisms (Griese, 1999). A complex oligosaccharide is also attached 
to this region of the SP-A molecule. 
Because of their mixed collagen-like and globular structure, such molecules 
are called collectins. The fully processed and secreted form of SP-A consists of 18 SP-A 
monomers (octadecamer or six trimers) organized by means of covalent disulphide 
bridges and non-covalent interactions in the shape of a bunch of tulips (Griese, 1999). 
The two genes for human SP-A are both located on chromosome 10 and are expressed 
in alveolar type II pneumocytes, bronchiolar Clara cells and airway submucosal gland 
cells (Griese, 1999). Surfactant protein A and B both have a role in the conversion of 
endogenous surfactant into tubular myelin. Surfactant protein A accelerates the 
adsorption of surfactant phospholipids at the air: liquid interface, stimulates the defence 
system that depends on macrophages (Wright, 1997), reduces the inhibitory effect on 
surface activity of the non-surfactant proteins within the alveolar space, and possibly 
plays a role in the regulation of surfactant homeostasis (Ledford et al., 2009).  
Surfactant protein D is the second hydrophilic surfactant protein and is also 
a collectin (Wright, 1997). The collagen-like domain of SP-D is much larger than that 
of SP-A and is attached directly to the carbohydrate recognition domain without a 
connecting region. The molecular weight of the SP-D monomer is approximately 39 
kDa. The native SP-D found in the lungs consists of 12 SP-D monomers, three of which 
are joined to form a trimer. Four trimers form a cross-shaped molecule. This cross-like 
structure (width of the molecule approximately 92 nm) may bind to bacterial 
lipopolysaccharides (LPS) and to cell surfaces, forming a large assembly of bacteria or 
cells (Griese, 1999). In addition, a receptor that binds SP-D, independent of its CRD 
domain, has been identified on alveolar macrophages (Holmskov et al., 1997). SP-D is 
expressed in type II pneumocytes and in Clara cells; in humans the gene is located on 
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chromosome 10. The majority (70%) of SP-D is found dissolved in the watery 
surfactant residue, whereas SP-A, SP-B and SP-C are almost entirely found in 
association with lipids. SP-D is able to bind to phosphatidylinositol (Griese, 1999). 
Surfactant protein C is the only surfactant protein that is exclusively 
expressed by type II pneumocytes in the mature lung. The human gene is found on 
chromosome 8; SP-C is translated as a larger precursor and is subjected to post-
translational processing. The active molecule is a very hydrophobic polypeptide and 
two palmitoyl groups are attached via covalent bonds (molecular weight is 
approximately 4 kDa). The most important function of SP-C is to maintain the 
biophysical surface activity of the lipids. This occurs through an acceleration of the rate 
of adsorption at the air: liquid interface as well as through an increase in the resistance 
of surfactant to inhibition by serum proteins. SP-C stabilizes the surface activity of the 
surfactant film during the expansion and compression involved in breathing (Griese, 
1999). Surfactant protein B and C also increase the uptake of phospholipids into type II 
pneumocytes.  
Intra-alveolar surfactant protein B is a hydrophobic, positively charged 
molecule with a molecular weight of 8.7 kDa. Human SP-B is coded by a gene on 
chromosome 2 and is expressed in type II pneumocytes and Clara cells. SP-B is shaped 
mainly in the form of a dimer in the alveolar space, with the two SP-B molecules 
connected to each other via disulphide bonds. The main function of SP-B is to speed up 
the formation of a surface active film composed of phospholipids at the air: liquid 
interface by means of an increase in the phospholipid adsorption rate. This effect is 
further accelerated by the presence of calcium ions. SP-B in conjunction with SP-A and 
calcium ions is also involved in the formation of tubular myelin (Griese, 1999).  
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 Type II cells can internalize surfactant components to be either degraded or 
recycled, thus suggesting that type II cells may serve both as a source of newly 
synthesized surfactant as well as a vehicle for clearance and recycling. It is reasoned 
that it is more economical in terms of cellular energy to recycle surfactant than to 
synthesise new material (Wright, 1990). 
1.6 Neonatal respiratory distress syndrome (NRDS)  
Neonatal respiratory distress syndrome, also known as hyaline membrane 
disease (Hallman and Haataja, 2007), is caused by alveolar collapse due to a deficiency 
of pulmonary surfactant (Ridsdale and Post, 2004; Zhang et al., 2004). The surface 
tension of the moist inner surface, which originates from molecular attraction within a 
fluid, has the potential to cause collapse of the lung. This tendency is minimized by the 
presence of surfactant that reduces the surface tension at the inner surface of the alveoli 
to a very low level. Evidence suggests that surfactant is needed in the alveolar region of 
the lung as well as in the respiratory bronchioles, which conduct air to the alveoli (Liu 
et al., 1991). In vitro studies have shown that a deficiency of surfactant leads to closure 
of these small cylindrical airways. In addition to this, the presence of proteases, and 
exuded plasma proteins in inflamed airways may harshly disrupt the functional ability 
of surfactant to keep the conducting airways open (Enhorning and Holm, 1993). 
Because of their small diameter, their ability to remain open is of particular importance 
to the physiological function of the alveoli. In areas with a relatively high surface 
tension (such as the alveoli) a thicker fluid film may build up. Thus, a well-functioning 
surfactant keeps the alveoli clear of liquid while also maintaining a thin surface film. A 
lack of surfactant, on the other hand, leads to the accumulation of oedematous fluid in 
the airspace. In general, pulmonary surfactant is believed to play a role in the physical 
removal of particulate material from the alveoli and small airways by means of the 
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displacement of particles into the hypo-phase and an improvement in the mucociliary 
clearance (Griese, 1999). 
Under normal conditions, abundant phospholipid components 
(phosphatidylcholine, phosphatidylglycerol, and phosphatidylinositol) have been shown 
to suppress various lymphocyte and macrophage immune functions, whereas SP-A and 
SP-D have been confirmed to activate several immune cell functions (Wright, 1997; 
Crouch, 1998). Glasser et al. (2001) noted that SP-C is essential for stabilization of 
surfactant at low lung volumes. Although antenatal glucocorticoid administration to the 
mother prior to delivery can significantly reduce the incidence of NRDS, intratracheal  
administration of pulmonary surfactant to preterm infants greatly reduces neonatal 
morbidity and mortality from NRDS (Jobe, 1993).  
In a recent study, Kevill et al. (2008) demonstrated that macrophage 
migration inhibitory factor (MIF) has a significant role in lung maturation during those 
stages of gestation when neonates are more susceptible to develop NRDS. MIF is 
expressed in bronchial epithelial cells and its concentration increases during gestation 
and subsequently declines to adult levels. Kevill and her coworkers found that higher 
intrapulmonary MIF levels were associated with lower likelihood of developing 
bronchopulmonary dysplasia, a result of NRDS.    
 Hallman and Haataja (2007) have stated that NRDS is a developmental 
disease caused by a number of factors. In addition to being induced by a transient 
deficiency of surfactant phospholipids, NRDS has been shown to be associated with 
allelic variants of the genes coding for the surfactant-associated proteins, SP-A, SP-B 
and SP-C. Furthermore, the preferential expression in type II cells of genes such as the 
ATP-binding cassette transporter, ABCA3 and those involved with known susceptibility 
to other severe lung diseases such as G protein-coupled receptor for asthma 
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susceptibility could also contribute to the development of NRDS (Hallman and Haataja, 
2007).   
1.7 Surfactant phospholipid synthesis 
Alveolar type II cells, responding to various other factors produced by 
accessory cells (such as lung fibroblasts) are the major site of surfactant phospholipid 
synthesis (Smith, 1978; Torday et al., 2002). Type II cells contain unique subcellular 
organelles called lamellar bodies consisting of many lamellae, which contain 
phospholipid bilayers, an electron dense core, and a surrounding limiting membrane 
(Snyder et al., 1981; Stahlman et al., 2000; Ridsdale and Post, 2004; Kirwin et al., 
2006). It has been shown that in late gestation undifferentiated,  glycogen-laden type II 
cells change their metabolic program in the direction of synthesis of surfactant 
(Ridsdale and Post, 2004). The assembly of surfactant in these cells is not only derived 
from newly-synthesized components, but also from components taken up by the type II 
cells via endocytosis thereby facilitating recycling of the surfactant components 
(Haagsman and Van Golde, 1991; Andreeva et al., 2007).  
1.8 Surfactant phospholipid secretion  
It is been proposed that direct stretching of type II pneumocytes during 
breathing is a physical stimulant to surfactant secretion (Lawson et al., 1979; Copland et 
al., 2006).
 
Mechanical distortion of the cells resulted in a transient increase in the 
intracellular Ca
2+
 concentration, which triggered an increased rate of surfactant 
secretion that persisted for up to 30 minutes (Wirtz and Dobbs, 1990; Copland and Post, 
2007). This delivery of surfactant to the alveolar space is preceded by this synthesis of 
the surfactant components followed by them being packaged into the subcellular 
lamellar bodies. Upon the receipt of an appropriate signal, the lamellar bodies 
accumulate adjacent to the apical plasma membrane where they fuse with the membrane 
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thus releasing the lamellar body contents. Secreted surfactant subsequently undergoes 
reuptake via endocytosis, intracellular processing and accumulation in lamellar bodies 
together with newly synthesized surfactant material. Therefore, intracellular surfactant 
is assembled from both newly synthesized and recycled surfactant components  
(Haagsman and Van Golde, 1991; Andreeva et al., 2007). 
1.9 Agents known to affect surfactant phospholipid synthesis 
 A wide range of hormones and other factors have been shown to influence 
the extent of surfactant phospholipid synthesis. In addition to glucocorticoids (which is 
discussed below), androgens, estrogens, growth factors (such as EGF and TGF-β), 
insulin, leptin, neuregulin-1β, prolactin and thyroid hormones have all been shown to 
influence the rate of surfactant phospholipid synthesis. In this chapter only some of the 
major factors will be discussed.  
1.9.1 Glucocorticoids 
 Since the pioneering work of Liggins (1969), who demonstrated that the 
administration of dexamethasone to fetal sheep accelerated the appearance of lung 
surfactant, a number of investigators have shown that glucocorticoids enhance the 
production of surfactant phospholipids in a variety of species, including the rabbit 
(Kotas and Avery, 1971), mouse (Brehier and Rooney, 1981) and rat (Smith and Sabry, 
1983). However, Dammann et al. (2006) have shown that this effect of glucocorticoids 
is influenced by the stage of development when administered to foetal mice. They 
demonstrated that whereas dexamethasone inhibited surfactant synthesis in immature 
type II pneumocytes at day 16 of gestation, it stimulated surfactant synthesis in the same 
cell type at day 17 of gestation. 
 As glucocorticoids are lipophilic their major mechanism of action involve 
them entering the target cell by diffusion across the cell membrane where they bind to 
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receptors located within the cell, as shown in Figure 1.3. An alternative, but less 
common, mechanism results from them binding to membrane-bound receptors. All the 
evidence (Post et al., 1986; Sen and Cake, 1991; Alangari, 2010) suggests that the effect 
of glucocorticoids in promoting surfactant phospholipid synthesis is the result of 
genomic interactions.    
This stimulatory effect is the result of an indirect action of glucocorticoids 
on lung fibroblasts to induce the production of a peptide, termed fibroblast-pneumocyte 
factor (FPF), which then acts upon the neighbouring type II cells to stimulate surfactant 
phospholipid synthesis (Post et al., 1984; Post et al., 1986) and surfactant protein A and 
B mRNA (Samtani et al., 2006) . Smith and  Fletcher  (1979)  observed that fetal lung 
pulmonary surfactant synthesis was dependent upon a molecular communication 
between mesenchymal cells and the neighbouring type II epithelial cells during 
pulmonary organogenesis. In particular, fibroblast-pneumocyte factor (FPF) was shown 
to be produced by the fetal lung fibroblasts in response to injecting fetal rats with 1 µg 
of glucocorticoids on the seventeenth day of gestation. Biochemical evidence of 
accelerated lung maturation was evident three days later. FPF, with a molecular weight 
of 5-15 kDa, is a heat stable, dialyzable polypeptide, which stimulates the biochemical 
activities of type II pneumocytes to synthesize and secrete pulmonary surfactant (Smith 
and Post, 1989). 
1.9.2 Neuregulin 
The neuregulins are a family of EGF-like growth factors that have been shown to be 
present in an increasing number of tissues and organisms (Carraway III et al., 1997; 
Zhao et al., 1998; Falls, 2003). Neuregulin, originally termed glial growth factor, was 
first purified from brain tissue (Brockes et al., 1980).  In other mammalian tissues it was  
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Figure 1.3  Mechanisms by which the actions of glucocorticoids are mediated.   
(A) Direct DNA binding or (B) transcription factor inactivation.  Non-genomic actions 
are mediated by (C) membrane-bound receptors, (D) cytosolic receptors or (E) 
interaction with cell membrane. cGR, cytosolic glucocorticoid receptor; mGR, 
membrane-bound glucocorticoid receptor; LBD, ligand-binding domain; DBD, 
DNA-binding domain; hsp 90, heat-shock protein 90; RE, response element; NFkP, 
nuclear factor k P; AP-1, activating protein-1 (Alangari, 2010). 
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named acetylcholine receptor-inducing activity (Falls et al., 1990), neuregulin 
differentiation factor (Peles et al., 1992) and heregulin (Holmes et al., 1992). It was not 
until the 1990s (Marchionni et al., 1993) that all of these different compounds were 
ascertained as the same protein and given the consensus name neuregulin, now known 
as neuregulin-1. This is because there are a number of neuregulins, many of which 
differ significantly in molecular weight and have a great variety of activities (Lemke, 
1996). Thus, neuregulins belong to a multi-protein family of epidermal growth factor-
like factors that arise from splice variations of a single gene (Carraway III et al., 1997). 
The isoforms of neuregulin-1 are all generated from a single gene (Lemke, 1996), 
however, three other genes encoding neuregulin have also been discovered: neuregulin-
2, 3 and 4 (Busfield et al., 1997; Zhang et al., 1997; Harari et al., 1999). Little is known 
about the function of the proteins encoded by these three genes, although they are 
known to bind to the same receptors as neuregulin-1 (Falls, 2003) . Neuregulin-2 has 
been shown to elicit different responses to neuregulin-1 when binding to the same 
receptor (Crovello et al., 1998). Unless otherwise stated, this review will focus solely on 
neuregulin-1.   
 Dammann et al. (2003) have shown that the stimulation of surfactant 
synthesis in type II cells by media, previously conditioned by fibroblasts in the presence 
of dexamethasone, can be mimicked by neuregulin-1β and inhibited by antibodies 
raised against this peptide. Thus neuregulin-1β plays a major role in the development 
and maturation of the fetal lung, preparing the lung for its function as an organ for gas 
exchange. These authors suggested that neuregulin-1β is a growth factor involved in 
many different stages of human development. Furthermore, Maker (2008) has shown 
that exposure of lung fibroblasts to dexamethasone leads to elevated levels of 
neuregulin-1β in the conditioned media. It is therefore possible that FPF may actually 
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be neuregulin-1β and its action involves interplay between neuregulin-1β and its 
specific receptors.  
 Neuregulin-1β has been shown to stimulate both cell growth and 
differentiation of target tissues by binding to ErbB3 and ErbB4 receptors and stimulates 
the tyrosine phosphorylation of other ErbB receptors through receptor 
heterodimerization (Riese et al., 1995; Carraway III et al., 1997; Crovello et al., 1998; 
Mautino et al., 2004). This ligand-induced heterodimerization is triggered by the 
bivalent nature of the ErbB ligands, a property which determines the specificity of 
dimerization. Of all these subtypes, the ErbB2 appears to be of particular importance as 
it is capable of forming dimers with ErbB1, ErbB3 and ErbB4. Structural studies have 
revealed that ErbB2 has a conformation which makes it constitutively available for 
dimerization (Cho et al., 2003; Citri et al., 2003) (Figure 1.4).  
  More recently, Zscheppang et al. (2007) and Liu et al. (2009) used a 
small interfering RNA (siRNA) against the ErbB4 gene to shut off ErbB4 receptor 
function in cultures of primary day 19 fetal rat lung type II cells. They showed that 
ErbB4-siRNA treatment not only diminished ErbB4 receptor protein expression, but 
also inhibited fibroblast-conditioned media (FCM)-induced ErbB4 phosphorylation, 
proliferation of the type II cells and the onset of fetal surfactant phospholipid synthesis 
through activation of the ErbB4 receptor. On the basis of a subsequent study it was 
concluded that deletion of pulmonary ErbB4 delayed both structural and functional 
aspects of fetal lung development, implying a crucial role for ErbB4 in the timely 
progression of fetal lung development (Liu et al., 2010). 
 In human airway epithelia neuregulin is released from the apical membrane 
of the type II pneumocytes and is physically separated from ErbB2, ErbB3 and ErbB4 
receptors, which are all located in the basolateral membrane. However, neuregulin finds  
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Figure 1.4 Structural conformation of the ErbB receptor family.  
        (A) structural conformations of individual members of the ErbB 
receptor family (B) ErbB is made up of back-to-back dimer, such that a dimerization 
arm from domain II of one subtype binds to a docking site at the base of domain II 
within the second subtype (Baselga and Swain, 2009).    
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its way to the basolateral part of the type II cells and creates a ligand-receptor pair 
poised for activation whenever epithelial integrity is disrupted by injury (Vermeer et al., 
2003). 
1.9.3 Leptin 
Leptin is a protein of 167 amino acids that is secreted by adipocytes and is essential in 
the regulation of energy balance within organisms  (Hoggard et al., 1997). It  is a 16 kD  
hormone  that  participates  in  metabolic  regulation,  and  also  has  role in 
inflammatory and immune reactions (Bruno et al., 2009). This is evident from the 
observation that there is a decreased expression of leptin in the bronchial epithelium of 
untreated  asthmatics (Bruno et al., 2009). Hoggard et al. (1997) have shown that there 
is a high level of expression of leptin and its receptor in the lung of the 14.5-day mouse 
fetus suggesting that leptin may have a role in growth and development of this tissue.  
Torday et al. (2002) and Kirwin et al. (2006) have independently shown that 
during rat lung development the expression of leptin by lipofibroblasts begins on 
embryonic day 17 and increases 7-10 fold by day 20. Leptin and its receptor are 
expressed exclusively by fetal lung fibroblasts and type II cells, respectively, which 
suggest the existence of a paracrine signaling loop. Using this mechanism, leptin 
stimulates the synthesis of surfactant phospholipid in both fetal rat type II cells and 
adult human airway epithelial cells. Leptin is secreted by lipofibroblasts in amounts that 
stimulate type II cell surfactant phospholipid synthesis in vitro. The synthesis and 
secretion of leptin by lung lipofibroblasts has been shown to be significantly enhanced 
when the cells are exposed to dexamethasone for 24 hours (Torday et al., 2002). Such 
an observation is consistent with findings of Slieker et al. (1995) who showed that 
glucocorticoids increased both the levels of leptin mRNA and secretion of leptin from 
adipocytes.  
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 The expression of parathyroid hormone-related protein (PTHrP) and 
PTH/PTHrP receptor are developmentally regulated in lung epithelial and mesenchymal 
cells, respectively (Rubin et al., 2004). These authors investigated mice in which the 
gene encoding PTHrP was removed by homologous recombination using both in vivo 
and in vitro models. They found that fetal and newborn mice experienced delayed 
mesenchymal-epithelial interactions, arrested type II cell differentiation, reduced 
lamellar body formation and diminished pulmonary surfactant production. This was 
confirmed by Torday and Rehan (2006) who showed that PTHrP has its effect via 
increased levels of leptin. More recently it has been shown that during lung 
development in the Xenopus laevis tadpole leptin increased not only lung surfactant 
synthesis but also the size of the lamellar bodies and the diameter of the alveoli  
(Torday et al., 2009).  
Leung et al. (2006) demonstrated that glucose up-regulated not only the 
expression of leptin receptor in human peritoneal mesothelial cells but also the 
expression of leptin by adipocytes. By stimulating the level of leptin receptor, glucose is 
able to enhance the leptin-induced synthesis of TGF-β in these mesothelial cells. This 
latter process results from the activation of the Janus kinase-signal transducers and 
activation (JAK-STAT) signal transduction pathway.  
1.9.4 Transforming growth factor-β (TGF-β) 
While Dammann and Nielsen (1998) found that TGF-β increases EGF-R 
binding in lung fibroblast cultures from late gestation fetuses, Torday and Kourembanas 
(1990) demonstrated that TGF-β inhibits the development of lung cell maturation at 
specific gestational stages by blocking type II pneumocyte maturation. Moreover, 
McDevitt et al. (2007) have shown that endogenous TGF-β not only inhibits early 
morphogenesis but also blocks glucocorticoid-induced type II cell differentiation. As 
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these later authors found that dexamethasone reduced TGF-β bioactivity by decreasing 
TGF-β gene expression, they concluded that endogenous TGF-β suppresses normal lung 
development and proposed that glucocorticoid-induced type II cell differentiation is 
likely to involve attenuation of this suppression by TGF-β.   
When one takes into account the influence of all of the afore-mentioned 
factors on surfactant synthesis it suggests that FPF, which stimulates the synthesis of 
surfactant in type II cells, could be NRG, leptin, PTHrP, or a combination of them all. 
Alternatively, glucocorticoids could stimulate type II cell differentiation by reducing 
synthesis of TGF-β in the fibroblasts and thereby attenuating the inhibitory effect of 
TGF-β (McDevitt et al., 2007). 
1.9.5 Other agents  
 A number of other studies have shown that surfactant phospholipid 
synthesis is induced by EGF and gastrin-releasing peptide (GRP) (Sunday et al., 1990; 
Fraslon and Bourbon, 1992; Emanuel et al., 1999), keratinocyte growth factor (KGF) 
(Xu et al., 1998; Chelly et al., 1999; Geshe et al., 2011) and retinoids (Fraslon and 
Bourbon, 1994). KGF, otherwise known as fibroblast growth factor 7 (FGF-7), is a 
product of lung mesenchymal cells and has been shown to stimulate both the synthesis 
of the major component of surfactant, namely disaturated phosphatidylcholine, and the 
expression of the SP-A, -B and –C genes in a dose-dependent manner (Chelly et al., 
1999).      
1.10 Agents known to affect surfactant phospholipid secretion  
Although Dobbs and Mason (1979) were not clear on what factors 
controlled the secretion of pulmonary surfactant from alveolar type II pneumocytes in 
vivo, with the use of cultured cells they were able to verify that the β-adrenergic agonist 
(–)-isoproterenol stimulates surfactant secretion from type II cells. Other investigators 
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have shown that  epidermal  growth  factor (EGF)  (Sen, 1991), gastrin releasing peptide 
(GRP) and bombesin (Shan et al., 2004) also stimulate the rate of secretion of surfactant 
lipids from cultured fetal rat type II pneumocytes (Asokananthan and Cake, 1996). The 
latter authors found that there was no response to GRP in the presence of saturating 
concentrations of A23187 or phorbol 12-myristate 13-acetate, implying that the 
secretory response to GRP is through activation of Ca
2+
/calmodulin-dependent protein 
kinase and/or protein kinase C and is independent of adenosine 3´,5´-cyclic 
monophosphate-dependent protein kinase. 
In a review article, Rooney (2001) stated that surfactant secretion is 
mediated by three different signalling pathways involving protein kinase A (PKA), 
protein kinase C (PKC) or calcium/calmodulin-dependent protein kinase (CaCM-PK). 
These signalling pathways are activated by a variety of secretagogues, some of which 
may be physiological regulators. In addition to those mentioned above, adenosine 5’-
triphosphate (ATP) has been shown to interact with P2y-purinoceptors thereby inducing 
Ca
2+
 mobilization, which leads to secretion of surfactant from type II cells (Rice and 
Singleton, 1987; Dorn et al., 1989). Activation of these protein kinases leads to 
phosphorylation of proteins, which act to increase surfactant secretion through 
exocytosis of the lamellar bodies (Rooney, 2001). The proposed signalling transduction 
pathways involved in the secretion process are shown in Figure 1.5. 
1.10.1 β-Adrenergic agonists 
 β-Adrenergic agonists are thought to raise the rate of surfactant discharge 
by enhancing the production of the secondary messenger, cyclic AMP. Binding of 
β-agonists to their specific receptors activates adenylyl cyclase via a stimulatory G 
protein (Aksoy et al., 2002).  The resulting  production of the second messenger, cAMP, 
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Figure 1.5 Signalling pathways leading to surfactant secretion (Rooney, 2001). 
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activates PKA leading to phosphorylation of cellular proteins. The increase in cAMP 
concentration, and  its  participation in  motivating  surfactant secretion via β-adrenergic 
receptor activation, has been implicated by the observation that (–)-isoproterenol causes 
a rise in the cAMP concentration in type II cells (Brown and Longmore, 1981).  
 The β-adrenergic receptor, which is located throughout the lung (Mutlu and 
Factor, 2008)  and  to  which  the  β-agonists  bind,   is a  member of a  large subfamily 
of G protein-coupled receptors (GPCRs) that contain seven hydrophobic domains that 
span the cell membrane and are connected to each other by hydrophilic extracellular and 
intracellular loops (Strader et al., 1995). Brown and Longmore (1981) have shown that 
the β-agonist-receptor interaction leads to the activation of a Gs protein, which  results  
in  an  elevated  level  of  cyclic AMP via the stimulation  of  adenylyl  cyclase. This 
was confirmed  by  inhibition of cyclic-AMP production when an antagonist, alprenolol, 
was used in place of the agonist (Brown and Longmore, 1981). Moreover, Abraham et 
al. (2004) demonstrated a functional coupling between the β-AR level and the degree of 
activation of adenylyl cyclase in the cultured alveolar cell type A549.  
Heterologous regulation of β-AR levels by glucocorticoids is a 
physiologically important example of how other factors can influence the regulatory 
processes exerted by β-adrenergic agents (Collins et al., 1988; Hadcock and Malbon, 
1988; Hadcock et al., 1989). Numerous in vitro and in vivo studies have shown that the 
β-AR level and β-agonist-stimulated adenylyl cyclase activity are amplified by 
glucocorticoids (Cheng et al., 1980; Giannopoulos and Sommers Smith, 1982; 
Maniscalco and Shapiro, 1983; Norris et al., 1987; Collins et al., 1988; Dangel et al., 
1996). The increase in β-AR numbers results from an increase in the rate of synthesis of 
new receptors (Norris et al., 1987; Collins et al., 1988), which is preceded by increased 
steady state levels of β-AR mRNA (Collins et al., 1988; Mak et al., 1995a; McGraw et 
Chapter 1  Introduction 
29 
 
al., 1995; Cornett et al., 1998; Aksoy et al., 2002). Isoproterenol decreased β1- and 
β2-receptor numbers by 48 and 51% and also reduced mRNA expression by 69 and 
57%, respectively. The combination of dexamethasone and isoproterenol did not change 
the level of β2-receptors, but there was a major reduction of β1-receptor and its mRNA 
expression. From these findings, Mak and his coworkers concluded that glucocorticoids 
can prevent homologous down regulation of β2-receptor numbers and mRNA 
expression (Mak et al., 1995b). 
Recent findings have shown that the enhancement of the β-adrenergic 
response in type II cells by glucocorticoids is notably greater if the cells are exposed to 
culture media that has been conditioned by cultured lung fibroblasts in the presence of 
the steroid (Damas, 2010). This suggests that this effect of glucocorticoids may also 
involve fibroblast pneumocyte factor (FPF). Moreover, these latest findings have shown 
that there is a marked sex-linked difference in the stimulation of β-AR levels in 
response to glucocorticoids. 
1.11 Effect of gender and gestational age on lung maturation 
As described previously, surfactant deficiency is a major contributor to 
prenatal mortality in preterm infants. Miller & Futrakul (1968) demonstrated that NRDS 
occurs more often in male than in female infants, because lung maturation is less 
advanced in males (Torday et al., 1981). Nielsen (1989) found that growth factors play 
a significant role in regulating the orderly progression of organ growth and 
differentiation during fetal development. He found that FPF is normally not produced 
by day 16 fibroblasts. In female-derived fibroblasts it initially appears on day 17 but in 
male derived fibroblasts its appearance does not occur until day 18. Exposure of the 
fibroblasts to EGF advanced this pattern by 24 hours such that female- and 
male-derived fibroblasts produced activity on day 16 and 17, respectively. By studying 
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two strains of mice with a gestational duration that differed by one day,  Besnard et al. 
(2011) demonstrated that both fetal and maternal genotypes influences not only the 
timing of birth but also the extent of lung maturation at birth. Moreover, they identified 
an important role for the transcription factors CCAAT-enhancer binding protein alpha 
(CCAAT-EBPα) and cAMP response element-binding protein (CREB) in maternally 
induced lung maturation.  
It is well established that surfactant appears earlier in the lungs of female 
fetuses (Nielsen and Torday, 1981; Torday et al., 1981; Nielsen et al., 1982; Torday, 
1984). The earlier formation of surfactant in female neonatal lungs favors patency of 
small airways leading to a higher airflow and lower airway resistance compared with 
lungs of neonatal males. Androgens have been shown in a variety of species to inhibit 
fetal lung surfactant production by altering epidermal growth factor and transforming 
growth factor-β signalling events (Carey et al., 2007b). In contrast, estrogens have been 
shown to exert a stimulatory effect, which is mediated by the α and β forms of the 
estrogen receptor (ERα and ERβ) in mice (Dammann et al., 2000). In mice and rats 
adult females have more and smaller alveoli than their male counterparts, an attribute 
that is also mediated by ERα and ERβ (Massaro and Massaro, 2006; Carey et al., 
2007a).   
 As the gestational age at which pulmonary surfactant production is acquired 
is later in male fetuses, it is not surprising that this correlates with a higher incidence of 
NRDS in prematurely delivered males (Miller and Futrakul, 1968; Nielsen et al., 1982; 
Provost et al., 2009). More recently, it has been shown that there is also a sex-linked 
difference in the expression of ApoA-1, ApoA-II, ApoC-II and ApoH in fetal type II 
pneumocytes, with the expression of these genes being higher in cells derived from 
females (Provost et al., 2009). They concluded that apolipoproteins had a role in lipid 
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metabolism and transport in the developing lung in association with the sex difference 
in synthesis of the surfactant lipids.  
1.12 Research proposal 
As discussed, Smith (1979) demonstrated that FPF was produced by the 
fetal lung fibroblasts in response to treatment with glucocorticoids and that this peptide 
was able to accelerate lung maturation through its ability to stimulate the synthesis and 
secretion of pulmonary surfactant in type II pneumocytes (Smith and Post, 1989). Since 
that time there have been numerous attempts to identify FPF. Torday and his coworkers 
(2002) found that during rat lung development, lipofibroblasts express leptin from a 
gestation age of 17 days. Leptin stimulates the synthesis of surfactant phospholipid in 
both fetal rat type II cells (Torday et al., 2002; Kirwin et al., 2006) and adult human 
airway epithelial cells (Torday et al., 2002). Using semi-quantitative RT-PCR, it was 
shown that the expression of leptin was elevated when fetal rat lung fibroblasts were 
exposed to 10 nM of dexamethasone for 24 hours (Torday et al., 2002). 
 Subsequently, Dammann et al. (2003) showed that the stimulatory effect of 
fibroblast conditioned media on surfactant synthesis by type II cells could be mimicked 
by exogenous neuregulin-1β and blocked by a neutralizing neuregulin-1β antibody. 
Moreover, both FCM and neuregulin-1β stimulated ErbB2 receptor phosphorylation in 
type II cells. More recently, it has been shown that exposure of cultured fetal lung 
fibroblasts to dexamethasone increases the concentration of neuregulin-1β in the FCM 
(Maker, 2008). 
 The above findings suggest that the main component of FPF, which 
stimulates type II cells to synthesize and secrete pulmonary surfactant, could be leptin, 
neuregulin or a combination of both (Figure 1.6). Although previous studies indicate 
that KGF is  synthesized by  mesothelial cells  and stimulates the synthesis of surfactant  
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Figure 1.6 Proposed actions of glucocorticoids, leptin and neuregulin-1β in 
the direct and indirect stimulation of surfactant phospholipids 
synthesis and secretion from type II pneumocytes.  
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components, its size (28 kDa; (Rubin et al., 1989) is much larger than the 5-15 kDa 
ascribed to FPF (Smith and Post, 1989). Thus, in this study the focus was  on  the  
specific  effects  of  leptin  and  neuregulin-1β  on  surfactant  phospholipid  synthesis 
and secretion  in  cultured  fetal  type II  pneumocytes.  In particular, the specific aims 
were as follows:  
 As the concentration of neuregulin-1β in fibroblast-conditioned media is 
elevated in response to glucocorticoids, the level of expression of neuregulin-1β 
will be used to determine whether or not glucocorticoids are able to up-regulate 
neuregulin-1β gene expression in cultured fetal rat lung fibroblasts.  
 The impact of dexamethasone on the expression of this gene will be compared 
with that of TGF-β1, a gene known to be suppressed by this steroid (McDevitt et 
al., 2007).  
 To compare the time- and concentration-dependence of both neuregulin-1β and 
leptin stimulation of surfactant phosphatidylcholine synthesis in type II cells.  
 To test the direct effect of leptin and neuregulin-1β on the secretion of surfactant 
phosphatidylcholine from cultured type II pneumocytes.  
 To ascertain the effect of neuregulin-1β on the activity of the β-adrenergic 
receptor in type II cells and to examine this in conjunction with the ability of the 
secretagogue, (–)-isoproterenol, to stimulate surfactant phosphatidylcholine 
secretion.  
 To determine if the secretory response of type II cells to neuregulin-1β is 
influenced by the sex of the donor animal. 
 qPCR will be used to ascertain the direct effects of both glucocorticoids and 
neuregulin-1β, alone and in combination, on the expression of the β-AR gene in 
cultured type II pneumocytes.   
  
 
Chapter 2 
Regulation of surfactant phospholipid synthesis and secretion 
by neuregulin-1β, leptin and (–)-isoproterenol from cultured 
fetal type II pneumocytes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 Regulation of surfactant synthesis and secretion 
34 
 
2.1  Introduction 
Dexamethasone administration not only induced early delivery when 
injected into fetal lambs but also stimulated aeration of their lungs, which suggested that 
glucocorticoids may accelerate the appearance of surfactant (Liggins, 1969). A 
subsequent study showed that infants of women undergoing premature birth had a 
markedly reduced incidence of respiratory distress syndrome if the mothers were treated 
with glucocorticoids prior to delivery (Liggins and Howie, 1972). Further work has 
shown that glucocorticoids enhance the production of surfactant phospholipids in a 
variety of species, including the rabbit (Kotas and Avery, 1971), mouse (Brehier and 
Rooney, 1981) and rat (Smith and Sabry, 1983). Smith and colleagues have shown that 
the stimulation of lung maturation by glucocorticoids is an indirect effect involving a 
mesenchymal-epithelial cell interaction (Smith, 1978; Smith, 1979). They suggested 
that glucocorticoids stimulate lung fibroblasts to produce a peptide that they termed 
fibroblast-pneumocyte factor (FPF), which acts on the type II pneumocytes to enhance 
surfactant phospholipid synthesis (Post et al., 1984; Post and Smith, 1984). 
Torday and his colleagues have shown that, in response to being stretched, 
type II cells secrete parathyroid hormone-related protein (PTHrP), a product that 
stimulates pulmonary surfactant production by a paracrine feedback loop mediated by 
leptin, a soluble product of the mature fibroblast (Torday and Rehan, 2002). 
Furthermore, they have shown that leptin is released from fetal rat lung fibroblasts in 
response to dexamethasone exposure and that leptin, acting via specific receptors, is 
able to directly stimulate surfactant phospholipid synthesis in type II cells (Torday et 
al., 2002). On the basis of these observations, they have suggested that leptin might be 
FPF. However, neuregulin-1β has also been shown to play a major role in the 
development and maturation of the fetal lung, preparing the lung for its function as an 
organ for gas exchange. Dammann et al. (2003) have provided evidence that the 
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stimulation of surfactant synthesis in type II cells by media, previously conditioned by 
fibroblasts in the presence of dexamethasone, can be mimicked by neuregulin-1β and 
inhibited by antibodies raised against this peptide. Moreover, Maker (2008) has shown 
that, by exposing lung fibroblasts to dexamethasone, the concentration of neuregulin-1β 
in the conditioned media was elevated by more than 2-fold. It is thus concluded that the 
‘FPF’ response may actually be due to a combination of factors that includes both leptin 
and neuregulin-1β. 
In this study, the focus of attention was heregulin-1β, a commercially 
available form of recombinant human neuregulin-1β. This peptide is a 7.5 kDa 
polypeptide consisting of the EGF-domain of human neuregulin-1β, which is known to 
exert its effect by binding to ErbB3 and ErbB4 receptors triggering their 
heterodimerization with ErbB2 and thus stimulating its associated tyrosine kinase 
(Crovello et al., 1998; Dammann et al., 2006). Activation of these receptors has been 
shown to result in differentiation of the lung (Dammann et al., 2003) and other tissues 
(Lemke, 1996; Burden and Yarden, 1997). 
Exposure of mature (d18) mouse type II pneumocytes to dexamethasone has 
been shown to increase the expression of the receptors for neuregulin, namely the ErbB 
receptors, and also influence their pattern of dimerization (Dammann et al., 2006). 
Neuregulin-1β and fibroblast-conditioned media have both been shown to elevate the 
levels of total and phosphorylated ErbB4 receptors (Zscheppang et al., 2007; Liu et al., 
2009), as well as surfactant phospholipid synthesis and cell proliferation. These 
observations imply that ErbB4 receptors and, by inference, neuregulin-1β play a central 
role in facilitating the stimulation of surfactant phospholipid synthesis that is indirectly 
induced by glucocorticoids. 
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The secretion of surfactant phospholipids from type II cells is known to be 
regulated by β-adrenergic agonists (Dobbs and Mason, 1979; Brown and Longmore, 
1981), which are released at the time of birth. Numerous in vitro and in vivo studies 
have shown that the β-AR level and β-agonist-stimulated adenylyl cyclase activity are 
amplified by glucocorticoids (Cheng et al., 1980; Giannopoulos and Sommers Smith, 
1982; Maniscalco and Shapiro, 1983; Norris et al., 1987; Collins et al., 1988; Dangel et 
al., 1996). This has been shown to be the result of enhanced transcription of the β-AR 
gene (Mak et al., 1995a; McGraw et al., 1995; Aksoy et al., 2002), a consequence of the 
β-AR gene containing a glucocorticoid response element (Cornett et al., 1998). This 
heterologous regulation of the β-AR levels by glucocorticoids is a physiologically 
important example of how other factors can influence the regulatory processes exerted 
by β-adrenergic agents (Collins et al., 1988; Hadcock and Malbon, 1988). Recent 
findings have shown that the response to glucocorticoids is noticeably greater if the type 
II cells are exposed to culture media that has been conditioned by cultured lung 
fibroblasts in the presence of the steroid (Damas, 2010), which suggests that this effect 
of glucocorticoids may also involve FPF. Moreover, these latest findings have shown 
that there is a marked sex-linked difference in the stimulation of β-AR levels in 
response to glucocorticoids. 
In the current study the direct effects of neuregulin-1β on the rate of 
synthesis and secretion of surfactant phospholipids were examined in cultured fetal type 
II cells. The magnitude of these effects was also compared to those induced by leptin. In 
addition, the effects of neuregulin-1β on the type II cell β-AR level and the secretory 
response of these cells to (–)-isoproterenol were ascertained. The latter two 
investigations were carried out on type II pneumocytes that had been derived from 
either male or female rat fetal lungs. 
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2.2 Materials and methods  
2.2.1 Animals   
      Nineteen-day pregnant rats of the Wistar strain of Rattus norvegicus were 
used for all experiments. The full gestation period of these animals is 22 days, so fetuses 
were delivered approximately three days premature. Animals were supplied by the 
Animal Resource Centre (Murdoch, Western Australia), whose mating protocol 
involves caging male and female rats overnight, followed by vaginal smearing the next 
morning. If sperm are detected conception is considered to have occurred. This is 
accurate to within eight hours of actual conception and is designated to be day zero. All 
experiments complied with the National Health and Medical Research Council 
guidelines and were approved by Murdoch University’s Animal Experimentation Ethics 
Committee. 
 Sex of the fetuses was determined by differences in the external genitalia, 
which can be recognized as early as day 17 of gestation. The small urogenital orifice 
and the genital swellings are larger in males than in females. Also, the distance between 
the rectum and the urogenital sinus is greater in male rat fetuses (Nielsen and Torday, 
1983). 
2.2.2 Materials 
 Eagle’s minimal essential medium (MEM) was obtained from Invitrogen 
Pty. Ltd., Mulgrave, Victoria, Australia. Newborn calf serum was obtained from Trace 
Biosciences Pty. Ltd., New South Wales, Australia. Penicillin G, streptomycin sulphate, 
amphotericin B from Streptomyces sp (Fungizone), activated charcoal, (–)-isoproterenol 
hydrochloride, immunoglobulin G (IgG), dipalmitoyl phosphatidylcholine (DPPC) and 
dexamethasone were supplied by Sigma-Aldrich, St. Louis, MO, USA. Filters (0.45 µm 
and 0.22 µm) were purchased from Advantec MFS Inc., CA, USA and Millipore Pty. 
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Ltd., North Ryde, Australia, respectively. Collagenase A (Clostridium histolyticum) was 
a product of Hoffman-La Roche Ltd., Basel, Switzerland. Ascorbic acid was obtained 
from May and Baker Australia Pty. Ltd, West Footscray, Victoria, Australia. 
PerkinElmer Inc., Boston, USA supplied [
3
H-methyl]-choline chloride, 
L-α-phosphatidylcholine 1,2-[1-14C]-dipalmitoyl and 1-[4,6-propyl-3H]-dihydro-
alprenolol. Tissue culture plates (60 cm; Falcon 35-3002), 60 cm Primaria culture plates 
(Falcon 35-3802), Primaria 24-well tissue culture plates and Optilux Petri dishes 
(Falcon 1001) were supplied by Becton Dickinson, North Ryde, New South Wales, 
Australia. Recombinant human neuregulin-1β (heregulin-1β) and recombinant rat leptin 
were obtained from PeproTech, Rocky Hill, NJ, USA. Whatman GF/A glass microfibre 
filters were supplied by GE Healthcare UK Ltd. Buckinghamshire, UK.   Calcium 
chloride (CaCl2), D-glucose, hydrochloric acid (HCl), magnesium chloride (MgCl2), 
potassium chloride (KCl), sodium chloride (NaCl), sodium dihydrogen orthophosphate 
(NaH2PO4), disodium hydrogen orthophosphate (Na2HPO4), sodium hydrogen 
carbonate (NaHCO3), were all of analytical reagent grade. 
 
2.2.3 Preparation of materials for cell culture 
2.2.3.1 Charcoal treatment of newborn calf serum    
 Newborn calf serum (NBCS) was incubated with sterile, acid-washed 
charcoal (50 mg.mL
-1
 serum) for 30 minutes in a 37°C shaking water bath to remove 
endogenous steroids. Charcoal was then removed by two successive centrifugations at 
12096 g for 88 minutes at 4°C in a Beckman J2-21M/E centrifuge using a JA-20 rotor 
(Beckman Instruments, Palo Alto, CA, USA). Serum was filtered through a 0.45 μm 
Millipore GS filter to remove remaining charcoal, and then through a 0.22 μm Millipore 
filter to sterilize the serum. Charcoal-treated newborn calf serum was stored in 23 mL 
aliquots at -20°C. 
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2.2.3.2  Preparation of immunoglobin G (IgG) solution 
 An IgG solution was prepared by adding 100 mL of MilliQ filtered sterile   
water to 50 mg of purified IgG to yield a final concentration of 0.5 mg.mL
-1
. Aliquots of 
10 mL were then stored at -20°C. When required, IgG plates were prepared by 
dispensing 3 mL of the IgG solution onto Optilux bacteriological plates followed by 
air-drying of the dishes overnight at room temperature under ultraviolet light to 
maintain sterility. Prior to use, plates were washed 3 times with 10 mL of BSS. 
2.2.3.3 Preparation of balanced salts solution (BSS) 
 Balanced salts solution (BSS) was prepared by mixing 900 mL MilliQ 
water, 50 mL 20x saline solution and 50 mL 20x buffer solution. The solution was 
adjusted to pH 7.4 and filtered through a 0.22 μm Millipore filter to sterilize. 20x saline 
solution contains 2.74 M NaCl, 54 mM KCl, 20 mM CaCl2 and 20 mM MgCl2. 
20x buffer solution contains 119 mM NaHCO3, 111 mM D-glucose, 27 mM Na2HPO4 
and 3 mM NaH2PO4. 
2.2.3.4 Preparation of amphotericin B  
 Amphotericin B solution was made by adding 10 mL of MilliQ water to 
100 mg amphotericin B (Fungizone) and diluted with another 10 mL of MilliQ water to 
give a final concentration of 5 mg.mL
-1
. Aliquots of 1 mL were stored at -20°C. 
2.2.3.5 Preparation of culture media  
 Eagle’s minimal essential media (MEM) was reconstituted as specified by 
the manufacturer, supplemented with 0.2% NaHCO3 and the mixture adjusted to pH 7.4. 
Penicillin G and streptomycin sulphate were added to final concentrations of 
0.0715 g.L
-1
 and 0.1525 g.L
-1
, respectively. Media were sterilized by filtration through a 
0.22 μm Millipore filter and to each 208 mL an aliquot of amphotericin B (150 μL) was 
added. This solution is termed MEM
+
, indicating it is MEM plus antibiotics. To produce 
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MEM complete (MEM
C
), charcoal-treated, newborn calf serum was added to a 
concentration of 10%. 
2.2.3.6 Preparation of DPPC solution   
 DPPC (12.5 mg) was dissolved in 5 mL of chloroform to yield a final 
concentration of 2.5 mg.mL
-1
. 
2.2.3.7  Preparation of [
14
C]-labeled DPPC solution  
 Stock L-α-phosphatidylcholine 1,2-[1-14C]-dipalmitoyl was diluted with 
ethanol such that a 50 µL aliquot yielded 10,000 dpm. 
2.2.3.8 Preparation of heregulin-1β solutions  
 Lyophilized recombinant human neuregulin-1β (heregulin-1β; 50 μg) was 
dissolved in 500 µL MilliQ water and 25 µL aliquots dispensed into 1.5 ml 
microcentrifuge tubes, re-lyophilized and then stored at -20°C until use. Prior to use, 
heregulin-1β was redissolved in MilliQ water and appropriately diluted to yield the final 
concentrations referred to below. 
2.2.3.9 Preparation of leptin solutions  
 Lyophilized recombinant rat leptin (200 μg) was dissolved in 1 mL MilliQ 
water and 25 µL aliquots dispensed into 1.5 ml microcentrifuge tubes, re-lyophilized 
and then stored at -20°C until use. Prior to use, leptin was redissolved in MilliQ water 
and appropriately diluted to yield the final concentrations referred to below. 
2.2.4  Isolation of rat fetal lung cells 
2.2.4.1 Isolation of lung fibroblasts  
 Sterile techniques were used during cell isolation procedures, all of which 
were performed at room temperature unless otherwise stated. Nineteen-day pregnant 
rats were killed by anaesthesia with 80:20% CO2:O2 exposure for 2 minutes followed by 
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asphyxiation with 100% CO2 for another 2 minutes. Rats were sprayed with 70% 
ethanol prior to delivery of fetuses via Caesarean section. Fetal lungs were removed and 
placed in a Petri dish of warm BSS. Any other tissues, such as the heart and thymus, 
were removed and discarded. Lungs were briefly dried on a sterile napkin and then 
minced using a McIlwain tissue chopper (The Mickle Laboratory Engineering Co., 
Surrey, UK) set at 0.1 mm with two traverses, one perpendicular to the other. The 
minced tissue was then placed in a sterile flask with 0.75 mL warm BSS per lung 
containing collagenase A (0.247 U.mg
-1
) at a concentration of 0.225 mg.mL
-1
. The flask 
was then gassed with carbogen (95:5 O2:CO2) for 90 seconds to ensure sufficient 
oxygenation for cell survival, and incubated for 20 minutes in a 37°C shaking water 
bath. 
 Following incubation, the dissociated tissue was squeezed through two 
layers of sterile French voile using sterile forceps, into 30 mL centrifuge tubes. 
Additional warm BSS was added to ensure that all tissue was transferred from the 
culture flask to the tube. The mixture was centrifuged at 20 g at 4°C for two minutes in 
a Beckman GPR Centrifuge (Beckman Instruments, Palo Alto, CA, USA). The 
supernatant was removed and replaced with warm BSS, and the washing procedure 
repeated. MEM
+
 solution was added so that the cells from two lungs were resuspended 
in each millilitre and plated onto 6 cm Falcon 35-3002 tissue culture plates (3 mL per 
plate), which were subsequently incubated for 30 minutes at 37°C in a humidified CO2 
incubator (5% CO2 : 95% air) to allow adhesion of fibroblasts.  
 Following this incubation, non-adhering cells were removed from the plates 
after suspension by gentle swirling. To each of these tissue culture plates with the 
fibroblasts attached, 3 mL of serum-supplemented MEM
+
 (MEM
C 
) was added, prior to 
incubation in a CO2 incubator (5% CO2 : 95% air) for further studies. With appropriate 
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changes of the media, plates are considered to be confluent after at least 8 days of 
incubation and consist predominantly of fibroblast cells (Figure 2.1) 
2.2.4.2 Isolation of fetal type II pneumocytes 
 The non-adhering cells from the previously mentioned plates were transferred to 
an IgG-coated bacteriological plate (as described in 2.2.3.2). These plates were then 
incubated in a CO2 incubator for an additional 1 hour. Unlike most lung cells, type II 
pneumocytes lack the Fc-receptor region (Dobbs et al., 1986). This technique therefore 
allows lung cells, other than the type II cells, to bind to the IgG present on the plates, 
thus eliminating them from the cell mixture (Dobbs et al., 1986). Following this 
incubation, the non-adherent cells were transferred to a sterile Shott bottle after gentle 
panning of the IgG plates, and charcoal-treated NBCS was added to a final 
concentration of 10%. Depending on the type of plate used and the number of lungs 
required per plate, the cell suspension was diluted using MEM
C
. For phospholipid 
secretion experiments, a 0.5 mL aliquot was added to each 6 cm Primaria plate and 
incubated with 2.5 mL of MEM
C
 (equivalent to 1 lung/plate). For phospholipid 
synthesis experiments, a 0.25 mL aliquot was added to each 6 cm Primaria plate and 
incubated with 2.75 mL MEM
C
 (equivalent to 0.5 lung/plate). For the measurement of 
the β-adrenergic receptor level, 0.25 mL of diluted cell suspension was plated into each 
well of a Primaria 24-well tissue culture plate (6 lungs per 24-well plate). With 
appropriate changes of the media, the plates were considered to be confluent after 3 
days and consisted predominantly of type II cells (Figure 2.2), as judged by 
Papanicolaou staining (Kikkawa and Yoneda, 1974) and electron microscopy of the 
cells (Maker, 2008). 
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Figure 2.1 Phase contrast photomicrograph of a typical fibroblast culture 
derived from 19-day fetal rats.  
Fibroblasts were isolated from 19-day fetal rats and cultured as described in 2.2.4.1. 
After at least 8 days in culture a phase contrast photomicrograph was taken using an 
Olympus DP-10 digital camera in conjunction with an Olympus Model MP-2 inverted 
phase microscope including an LBT-N filter.   
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Figure 2.2 Phase contrast photomicrograph of a typical 19-day fetal type II 
pneumocyte culture. 
Type II cells were isolated from 19-day fetal rats and cultured as described in 2.2.4.2. 
After 4 days in culture a phase contrast photomicrograph was taken using an Olympus 
DP-10 digital camera in conjunction with an Olympus Model MP-2 inverted phase 
microscope including an LBT-N filter.   
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2.2.5  Conditions of cell culture 
 Cultures were maintained in a water-saturated atmosphere of 5% CO2 and 
95% air at a temperature of 37°C in a Forma Scientific 3250 water-jacketed CO2 
incubator (Forma Scientific, Division of Mallinckrodt Inc., OH, USA). To help 
maintain a sterile environment, 500 mL of Microshield 5 antiseptic solution (Johnson & 
Johnson, East London, UK) was added to the water pan, which was changed every three 
months. Type II cultures were given a media change at 24 hours post-plating. This 
involved removing media from the plates, washing with 3 mL of BSS and adding 3 mL 
of MEM
C 
to each plate. Type II cells were maintained in culture under these conditions 
for three days prior to changing the media to MEM
+
. 
2.2.6 Assay of surfactant phospholipid synthesis 
2.2.6.1 Effect of heregulin-1β and leptin on phospholipid synthesis in type II 
cells  
  Type II cells were prepared as described in 2.2.4. After 72 hours, the plates 
were removed from the incubator and the media removed. Plates were washed with 3 
mL of BSS, and the media replaced with 3 mL of MEM
+
. Control plates received 
30 µL water, while test plates received 30 µL of the indicated concentrations of either 
heregulin-1β or leptin. All plates were then incubated for a further 21 hours. 
 A solution of 7 µCi.mL
-1
 [
3
H-methyl]-choline chloride in MEM
+
 was 
prepared. The media was removed from each plate into sterilized tubes and 500 µL of 
the [
3
H-methyl]-choline chloride solution was added. The tubes were mixed and 
duplicate aliquots (50 µL) were removed to determine radiolabeled input concentration 
and the plates returned to the incubator for a further 2, 4 or 6 hour. The plates were then 
removed from the incubator and placed on ice to prevent further lipid synthesis. The 
media was removed and the plates washed three times with 3 mL of BSS. The cells 
were scraped from the plate with 1 mL of BSS followed by another 1 mL and collected 
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in pre-weighed conical centrifuge tubes, which was kept on ice until all plates had been 
harvested. The tubes were centrifuged at 1000 g at 4°C for two minutes and the 
supernatant was removed by aspiration and discarded. The centrifuge tubes were again 
weighed to allow calculation of the weight of cells harvested from each plate. BSS 
(400 µL) was added to each tube and the cells disrupted using a Braunsonic 1510 
sonicator with a microprobe (B. Braun, Melsungen, Germany) at 50 watts for 20 
seconds. 
 Duplicate aliquots (50 µL) of each sonicate were taken and dried in a 50°C 
oven to determine DNA content. Lipids were extracted from the sonicates using the 
method of Bligh and Dyer (1959) as follows: A 200 µL aliquot of the sonicate was 
taken and added to a tube containing 2 mL methanol, 1 mL chloroform, 600 µL of 
MilliQ H2O, 50 µL of L-α-phosphatidylcholine 1,2-[1-
14
C]-dipalmitoyl (approximately 
10,000 dpm) as a recovery standard, and 20 µL of 2.5 mg.mL
-1
 dipalmitoyl 
phosphatidylcholine as a carrier. The mixture was vortexed for 20 seconds and left to 
stand at room temperature for 10 minutes. This was followed by the addition of 1 mL of 
chloroform followed by 20 seconds of vortexing. After a further 10 minutes, 1 mL of 
MilliQ H2O was added, the tubes vortexed and placed in a 4°C refrigerator for at least 
48 hours. Triplicate aliquots (50 μL) of the L-α-phosphatidylcholine 1,2-[1-14C]-
dipalmitoyl input solution were also added to polyethylene vials for determination of 
the input dpm.  
 During the 48 hours of refrigeration, the chloroform and water/methanol 
separated into two distinct phases, with the lower phase containing the radioactively 
labelled lipid. The upper phase was removed by aspiration and duplicate 400 µL 
aliquots of the lower phase were taken and placed into scintillation vials. The contents 
of the vial were dried by evaporation for at least three hours and 3 mL of scintillant was 
added to each vial. The vials were then vortexed and left to stand at room temperature in 
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the dark for at least 48 hours prior to counting in a Beckman LS3801 scintillation 
counter (Beckman Instruments, Palo Alto, CA, USA). Tubes were subjected to dual 
label counting to determine both 
3
H and 
14
C. To determine the rate of synthesis of 
surfactant phospholipids, the following calculation was made: 
Surfactant lipid synthesis (dpm.μg DNA-1) = 
3
H dpm X 
14
C input (dpm) 
X 
1 
14
C recovered (dpm) μg DNA/200 μL 
 
 
 2.2.6.2 Fluorimetric DNA assay  
 A standard DNA solution was prepared by dissolving highly polymerized 
calf thymus DNA in MilliQ water to a concentration of 0.1 mg.mL
-1
. Duplicate 
standards containing 0, 1, 2, 3, 4 and 5 μg of DNA were prepared in separate tubes and 
dried in a 50ᵒC oven. The amount of DNA was determined using the method of 
Hinegardner (1971). To each of the standard and test tubes was added 100 µL of a 
0.4 g.mL
-1
 3,5-diaminobenzoic acid solution. They were then placed back in the 50°C 
oven for a further 45 minutes to allow product development. After this, 1.5 mL of 1.0 M 
HCl was added to each tube, the contents mixed and aliquots transferred to 96-well 
plates (Labtech Pty. Ltd., Victoria, Australia), which were then read in a Fluostar 
Optima plate reader (Walker Sales and Service, Perth, Western Australia) at an 
excitation wavelength of 405 nm and an emission wavelength of 520 nm. A typical 
standard curve is shown in Figure 2.3. 
2.2.7 Surfactant phospholipid secretion from cultured fetal type II cells 
2.2.7.1 Response to heregulin-1β and leptin 
 The rate of secretion of surfactant phospholipids from type II pneumocytes 
was determined after exposure of the cells to either heregulin-1β or leptin. After 72 
hours  of  culture,  the  media  was  changed  to  MEM
+
 supplemented with [
3
H-methyl]- 
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Figure 2.3 A typical standard curve for the fluorimetric assay of DNA. 
Standards containing the indicated amounts of highly-polymerised calf thymus DNA 
were assayed by the method of Hinegardner (1971) as described in 2.2.6.2. 
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choline chloride (1µCi.mL
-1
). Following incubation for a further 24 hours, the cultures 
were washed three times with 3 mL BSS to remove unincorporated choline and any 
detached cells before adding 1.7 mL of MEM
+
. The cells were allowed to equilibrate at 
37°C in a CO2 incubator for 1 hour prior to removing two plates to determine the media 
and cellular content of radiolabelled phospholipids. To the remaining plates (two for 
each treatment) was added 17 µL of MilliQ water as vehicle (control) or appropriately 
diluted solutions of heregulin-1β or leptin. The media and cellular content of 
radiolabelled phospholipids were again determined after 3 hours incubation of the cells 
with the peptides.   
2.2.7.2 Response to (–)-isoproterenol 
 Type II cells were isolated as described in 2.2.4. The effect of                     
(–)-isoproterenol on the rate of secretion of [3H]-choline-labelled surfactant 
phospholipids from cultured type II pneumocytes was measured as described by Sen 
and Cake (1991). After 72 hours growth in culture the medium was changed to MEM
+
 
supplemented with [
3
H-methyl]-choline chloride (1µCi.mL
-1
). Following further 
incubation for 24 hours, the cultures were washed with 3 mL BSS three times to remove  
unincorporated  choline  and  any  detached  cells  prior  to  adding  1.7 mL  of MEM
+
. 
The cells were allowed to equilibrate at 37°C in a CO2 incubator for 1 hour prior to 
removing two plates for the determination of both the media and cellular content of 
radiolabelled phospholipids (zero time). During this period of equilibration a 10 mM 
stock solution of (–)-isoproterenol, which had been prepared in 0.01M HCl and stored 
for up to 4 weeks at 4°C, was diluted in a solution containing 20 µg.mL
-1
 ascorbic acid 
to yield working solutions of 10 and 100 μM (–)-isoproterenol. Aliquots  (17 μL) of 
these latter solutions or an equivalent volume of 20 µg.mL
-1
 of ascorbic acid (control) 
were added to the remaining plates of type II pneumocytes, such that the final 
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concentration of (–)-isoproterenol was zero, 0.1 or 1 µM. The media and cellular 
content of radiolabelled phospholipids were again measured after an additional 3 hours 
of incubation.   
2.2.7.3  Response to (–)-isoproterenol after prior exposure to heregulin-1β 
 Rat type II pneumocytes were isolated from fetal lung tissue and grown in 
culture for 3 days as described in 2.2.4. The cells were then exposed to 50 ng.mL
-1
 
heregulin-1β as well as [3H-methyl]-choline chloride (in order to label surfactant 
phospholipids). After 24 h exposure the cells were washed three times with 3 mL BSS 
to remove unincorporated [
3
H-methyl]-choline chloride and the media replaced with 1.7 
mL of MEM
+ and the cells equilibrated for a further 1 hour prior to the addition of 1 μM 
(–)-isoproterenol or an equivalent volume of ascorbic acid solution (vehicle) as 
described in 2.2.7.1. Identical experiments were conducted on type II cells derived from 
either male or female fetal rats.  
2.2.7.4   Determination of the level of secretion of surfactant phospholipids from 
type II cells 
 The radiolabelled phospholipids in the media and cells were extracted 
according to the method of Bligh and Dyer (1959). After the cells had been incubated 
for 3 hours, the plates were placed on ice to prevent further secretion, the medium 
removed and the cells washed three times with 0.83 mL warm BSS. The media and 
washings from each plate were combined (4.2 mL total) and vortexed briefly prior to 
centrifugation for 2 minutes at 1000 g (2100 rpm) in a refrigerated GRP centrifuge 
(Beckman Instruments, Palo Alto, CA, USA) at 4°C to sediment any detached cells. A 
portion of the supernatant (3.2 mL) was transferred to screw-capped tubes for lipid 
extraction. The cells from each plate were also transferred into screw-capped tubes 
using a polyethylene scraper into a mixture of 0.8 mL of MilliQ water and 1.0 mL of 
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methanol, followed by a further scraping with 1.0 mL of methanol. To each of these 
tubes was added 50 µL of L-α-phosphatidylcholine 1,2-[1-14C]-dipalmitoyl 
(approximately 10,000 dpm) as a recovery standard, and 20 µL of 2.5 mg.mL
-1
 
dipalmitoyl phosphatidylcholine (DPPC) as a carrier. Triplicate 50 µL aliquots of the 
L-α-phosphatidylcholine 1, 2-[1-14C]-dipalmitoyl solution was also added directly to 
polyethylene vials to facilitate the determination of phospholipid recovery. To achieve 
the required chloroform: methanol: water ratio of 2.0: 2.0: 1.8, 12 mL of chloroform: 
methanol (1:2) mixture was added to the media samples, and 1 mL of chloroform was 
added to the cell samples and the mixtures vortexed. After 10 minutes, further additions 
of 4 mL of chloroform to the media tubes, and 1 mL of chloroform to the cell tubes 
were made and the mixtures vortexed again. After an additional 10 minutes, 4 mL and 1 
mL of MilliQ water was added to the media and cell tubes, respectively. After an 
additional vortex, the tubes were left to stand overnight at 4ᵒC.  
 The following day, after careful removal of the upper phase and protein 
interface (via aspiration), duplicate 3.5 mL aliquots of the chloroform layer of each 
media extraction tube and a 0.4 mL aliquot of each cell extraction tube were transferred 
to polyethylene counting vials. The solvent was evaporated from these vials under air at 
37°C in a Pierce Reacti-Therm III evaporator over a period of at least 4 hours. 
Optiphase “HiSafe” II scintillant (3 mL) was added to each vial, which was vortexed 
and the contents left for at least 48 hours in the dark. Radioactivity was determined in a 
Beckman LS 6500 liquid scintillation counter (Beckman Instruments Nuclear Division, 
Fullerton, CA, USA) in which the amounts of both [
3
H] and [
14
C] were measured. 
Finally, the results were expressed in disintegrations per minute and corrected for the 
recovery of [
14
C]. Media [
3
H] counts were also corrected for the fact that only a 3.2 mL 
aliquot, from a total volume of 4.2 mL, was extracted. The extent of [
3
H]-phospholipid 
secretion by the cells was calculated as follows: 
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% secretion = 
dpm in media phospholipids    
X 
100 
(dpm in media phospholipids)+(dpm in cellular phospholipids) 1 
 
2.2.8 Determination of the β-adrenergic receptor activity in type II cells 
 Type II pneumocytes derived from mixed sexes or separate male and female 
19-day fetal rat lungs as described in 2.2.4, were plated in Primaria 24-well tissue 
culture plates and maintained in MEM
C
. The media was changed after 24 hours of 
incubation and after a further 48 hours the cells were washed twice with 1 mL of BSS, 
prior to incubation for a further 24 hours with MEM
+
 containing heregulin-1β dissolved 
in water (final concentration 50 or 100 ng.mL
-1
) or an equivalent volume of water 
(control). At the end of this incubation, the cells were evaluated for β-adrenergic 
receptor activity using a technique previously described by Lefkowitz  et al. (1974). The 
media was removed and the cells were washed with 170 mM Tris-HCl buffer, pH 7.6 
containing 10 μM phenylmethylsulphonyl fluoride, as a protease inhibitor. The cells 
were then air-dried for a minimum of 2 hours and incubated with 5 nM of the 
β-adrenergic receptor radioligand, 1-[4,6-propyl-3H]-dihydroalprenolol ([3H]-DHA), 
dissolved in Tris-HCl. Non-specific binding was determined by incubating the cells 
with the radioligand in the presence of 10 μM (–)-propranolol. After 2.5 hours 
incubation, the type II cells were washed three times with 2 mL of Tris-HCl and wiped 
onto Whatman GF/A glass-fibre filter papers, which were then transferred to 
polyethylene counting vials for determination of radioactivity. Triplicate 100 μL 
aliquots of [
3
H]-DHA dissolved in Tris-HCl with and without 10 μM (–)-propranolol 
were also counted for quality control purposes.  
 Optiphase Hisafe-2 scintillant (3 mL) was added to each vial and vortexed 
prior to measuring radioactivity using a Beckman LS 6500 liquid scintillation counter 
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(Beckman Coulter Incorporated, Brea, CA, USA). An additional 8 wells, which had not 
been used for receptor assay, were dried at 50ᵒC and stored for DNA assay as described 
in 2.2.6.2. The receptor binding, expressed as fmole [
3
H]-DHA specifically bound per 
μg  of  DNA,  was  determined  by  subtracting  the  dpm  bound  in  the  presence  of  
(–)-propranolol (non-specific binding) from the dpm bound in its absence (total 
binding). 
2.2.9 Statistical analyses   
Results were tabulated and graphed using Microsoft Excel and statistical 
analyses were carried out using SPSS Statistics 21.0 for Windows. Repeated measures 
ANOVA (von Ende, 2001) was used to analyze the time course studies and for any 
differences between 3 or more experimental conditions. If the latter were significant, the 
ANOVA was followed by Dunnett pairwise comparisons to test for differences from the 
control group. 
2.3 Results 
2.3.1 Surfactant phospholipid synthesis 
2.3.1.1 Influence of heregulin-1β on surfactant phospholipid synthesis in type 
II cells 
 Type II pneumocytes isolated from the lungs of 19-day fetal rats were 
grown in culture for 72 hours and then incubated for a further 21 hours with 50 ng.mL
-1
 
heregulin-1β or vehicle (control) prior to being exposed to 1.0 μCi.mL-1 [3H-methyl]-
choline chloride. The quantity of radiolabelled surfactant phospholipids synthesised by 
these cells in the next 2, 4 and 6 hours was enhanced when compared with that which 
occurred in cells grown in the absence of heregulin-1β (Figure 2.4) This difference 
between control cultures and NRG1β-treated cells was significant (p < 0.05) and, as 
expected, there was also evidence of an increase in the extent of phospholipid synthesis 
with time (p < 0.01).  
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Figure 2.4 Time course of the effect of heregulin-1β on surfactant 
phospholipid synthesis. 
Rat type II pneumocytes were isolated from fetal lung tissue and grown in culture for 
3 days as described in 2.2.4. The cells were then washed with 3 mL BSS and the media 
replaced with 3 mL of MEM
+
 containing 50 ng.mL
-1
 heregulin-1β ( ) or an equivalent 
volume of vehicle (control,  ). After 21 h exposure, the cells were then exposed to 
1.0 μCi.mL-1 [3H-methyl]-choline chloride and re-incubated. The amount of 
phospholipids synthesised in the next 2, 4 and 6 h was determined as described in 2.2.6. 
The results represent the mean ± SEM of 8 separate experiments conducted in duplicate. 
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When type II cells were incubated with 0, 10, 20, 50, 100 or 200 ng.mL
-1
 
(i.e. 0 - 26.67 nM) heregulin-1β for 6 hours the quantity of labelled surfactant 
phospholipids synthesised was higher in those cells exposed to the peptide. However, 
only for those cells exposed to 20 and 50 ng.mL
-1
 heregulin-1β was this increase 
significantly different from the control (more than a 3-fold increase; p < 0.05). 
(Figure 2.5).  
2.3.1.2 Comparison of the stimulatory effects of heregulin-1β and leptin on the 
synthesis of surfactant phospholipids in type II cells     
 Previous studies have shown that leptin stimulates surfactant phospholipid 
synthesis in rat fetal type II pneumocytes (Torday et al., 2002; Kirwin et al., 2006; 
Torday and Rehan, 2007). When the stimulatory effects of heregulin-1β and leptin on 
surfactant phospholipid synthesis were compared, leptin, at both 20 and 50 ng.mL
-1
, 
showed a significant increase in surfactant phospholipid synthesis compared to the 
control (p < 0.05 and p < 0.01, respectively). In contrast, although heregulin-1β, at a 
concentration of 50 ng.mL
-1
, increased the amount of surfactant phospholipids 
accumulated, this effect was not significantly different from the control (Figure 2.6). 
This latter finding does not agree with the data shown in Figure 2.5, however, it must be 
noted that in this experiment with heregulin-1β the labeling time was only 4 h (not 6 
hours as in Figure 2.5). 
2.3.2 Surfactant phospholipid secretion 
2.3.2.1 Influence of heregulin-1β on surfactant phospholipid secretion  
 When cultured fetal type II cells were incubated in the presence of 
50 ng.mL
-1
 heregulin-1β there was a consistent increase in the rate of secretion of 
surfactant phospholipids from the type II cells as compared to that seen in the control 
cells (Figure 2.7;  p = 0.05)  and, as  expected,  there was  evidence of an increase in the  
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Figure 2.5 Effect of heregulin-1β concentration on surfactant phospholipid 
synthesis in cultured fetal type II pneumocytes. 
Rat type II pneumocytes were isolated from fetal lung tissue and grown in culture for 
3 days as described in 2.2.4. The cells were then washed with 3 mL BSS and the media 
replaced with 3 mL of MEM
+
 containing 10, 20, 50, 100 and 200 ng.mL
-1
 of 
heregulin-1β ( ) or an equivalent volume of vehicle. After 21 h exposure the cells were 
then exposed to 1.0 μCi.mL-1 [3H-methyl]-choline chloride and incubated for a further 
6 h. The amount of phospholipids synthesised was determined as described in 2.2.6. The 
results represent the mean ± SEM of 4 separate experiments conducted in duplicate. 
Those cells exposed to 20 and 50 ng.mL
-1
 heregulin-1β were significantly different from 
the control (p < 0.05), as indicated by the asterisks. 
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Figure 2.6 Effect of heregulin-1β and leptin on surfactant phospholipid 
synthesis in cultured fetal type II pneumocytes. 
Rat type II pneumocytes were isolated from fetal lung tissue and grown in culture for 
3 days as described in 2.2.4. The cells were then washed with 3 mL BSS and the media 
replaced with 3 mL of MEM
+
 containing 50 ng.mL
-1
 heregulin-1β ( ) or 20, 50 and 100 
ng.mL
-1
 leptin ( ) or an equivalent volume of vehicle (control, ). After 21 h exposure 
the cells were then incubated with 1.0 μCi.mL-1 [3H-methyl]-choline chloride and 
incubated for a further 4 h. The amount of phospholipids synthesised was determined as 
described in 2.2.6. The results represent the mean ± SEM of 4 separate experiments 
conducted in duplicate. Cells exposed to 20 (p < 0.05) and 50 ng.mL
-1
 of leptin 
(p < 0.01) were significantly different from the control, as indicated by the asterisks. 
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Figure 2.7 Time course of the effect of heregulin-1β on surfactant 
phospholipid secretion from cultured fetal type II pneumocytes. 
Rat type II pneumocytes were isolated from fetal lung tissue and grown in culture for 
3 days as described in 2.2.4. The cells were then exposed to 1.0 μCi.mL-1 [3H-methyl]-
choline chloride in order to label surfactant phospholipids. After 24 h exposure the cells 
were washed three times with 3 mL BSS to remove unincorporated [
3
H-methyl]-choline 
chloride and the media replaced with 1.7 mL of MEM
+ 
and the cells equilibrated for a 
further 1 h prior to the addition of 50 ng.mL
-1
 heregulin-1β ( ) or an equivalent volume 
of vehicle (control,  ). The amount of labelled phospholipid secreted into the media in 
the next 1, 2 and 3 h was determined as described in 2.2.7.4. The results represent the 
mean ± SEM of 7 separate experiments conducted in duplicate.  
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level of phospholipid secretion with time (p = 0.019). This effect of enhanced secretion 
was also evident at 10, 20 and 100 ng.mL
-1
 heregulin-1β, however only at a 
concentration of 50 ng.mL
-1
 heregulin-1β (2.4-fold; p < 0.05) was the rate of secretion 
significantly different from the control (Figure 2.8).  
 Whereas leptin had a stimulatory effect on the synthesis of surfactant 
phospholipids (Figure 2.6), at concentrations of 20-100 ng.mL
-1
 there is no significant 
effect on the rate of secretion from type II cells. This contrasts with the observation that 
50 ng.mL
-1
 heregulin-1β significantly increased both surfactant phospholipid synthesis 
(p < 0.05; Figure 2.5) and secretion (p < 0.05; Figure 2.9). 
2.3.3 Effect of heregulin-1β on β-adrenergic receptor level in type II 
pneumocytes 
Type II pneumocytes were isolated from 19-day fetal rat lung as described 
in 2.2.4 and incubated with MEM
C
 for 3 days. The medium was then replaced with 
MEM
+
  containing  50 or 100 ng.mL
-1
   of   heregulin-1β  and  the   cells   incubated  for 
a further 24 hours. The control cells had a mean [
3
H]-DHA binding level of 
0.55 fmol.μg-1 DNA, whereas cells exposed to 50 and 100 ng.mL-1 heregulin-1β had 
binding levels of 0.76 and 0.77 fmol.μg-1 DNA, respectively, which were both 
significantly higher than the control level (p < 0.05) and corresponded to an 
approximate 40% increase in the concentration of β-adrenergic receptors (Figure 2.10). 
Male and female fetuses from 19-day pregnant rats were separated as 
described in 2.2.1 and the type II pneumocytes isolated and cultured on 24-well plates 
as described in 2.2.4.2. The cells were grown for 72 hours in MEM
C
 prior to 24 hours 
exposure to either 50 ng.mL
-1
 heregulin-1β in 250 μL of MEM+ or 250 μL of MEM+ 
alone  (control).  The cells of  both sexes  were then analysed  for  β-adrenergic receptor  
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Figure 2.8 Effect of heregulin-1β concentration on surfactant phospholipid 
secretion from cultured fetal type II pneumocytes. 
Rat type II pneumocytes were isolated from fetal lung tissue and grown in culture for 
3 days as described in 2.2.4. The cells were then exposed to 1.0 μCi.mL-1 [3H-methyl]-
choline chloride in order to label surfactant phospholipids. After 24 h exposure the cells 
were washed three times with 3 mL BSS to remove unincorporated [
3
H-methyl]-choline 
chloride and the media replaced with 1.7 mL of MEM
+ 
and the cells equilibrated for a 
further 1 h prior to the addition of 10, 20, 50, 100 and 200 ng.mL
-1
 of heregulin-1β ( ) 
or an equivalent volume of vehicle. After 24 h exposure the cells were exposed to 
1.0 μCi.mL-1 [3H-methyl]-choline chloride and incubated for a further 3 h. The amount 
of phospholipids secreted was determined as described in 2.2.7.4. The results represent 
the mean ± SEM of 6 separate experiments conducted in duplicate. Cells exposed to 50 
ng.mL
-1
 heregulin-1β were significantly different from the control (p < 0.05), as 
indicated by the asterisk. 
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Figure 2.9 Effect of heregulin-1β and leptin on the secretion of surfactant 
phospholipids from cultured fetal type II pneumocytes. 
Rat type II pneumocytes were isolated from fetal lung tissue and grown in culture for 
3 days as described in 2.2.4. The cells were then exposed to 1.0 μCi.mL-1 [3H-methyl]-
choline chloride in order to label surfactant phospholipids. After 24 h exposure the cells 
were washed three times with 3 mL BSS to remove unincorporated [
3
H-methyl]-choline 
chloride and the media replaced with 1.7 mL of MEM
+ 
and the cells equilibrated for a 
further 1 h prior to the addition of 50 ng.mL
-1
 of heregulin-1β ( ), 20, 50 or 100 ng.mL-1 
leptin ( ) or an equivalent volume of vehicle (control, ). The amount of labelled 
phospholipid secreted into the media in the next 3 h was determined as described in 
2.2.7.4. The results represent the mean ± SEM of 5 separate experiments conducted in 
duplicate. Any result that is significantly different from the control (p < 0.05) is 
indicated with an asterisk. 
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Figure 2.10 Effect of heregulin-1β on β-adrenergic receptor level associated 
with cultured fetal type II pneumocytes. 
Rat type II pneumocytes were isolated from fetal lung tissue and grown in 24–well 
tissue culture plates for 3 days as described in 2.2.4. Cells were then incubated with 50 
or 100 ng.mL
-1 
heregulin-1β ( ) or vehicle (control, ) for 24 h. After being washed 
thoroughly using BSS, cells were then incubated with [
3
H]-DHA to allow binding of the 
radioligand to specific β-adrenergic receptors. The effect of heregulin-1β on the level of 
β-adrenergic receptors, measured as specific [3H]-DHA binding, was determined as 
described in 2.2.8. The results represent the mean ± SEM of 10 separate experiments 
conducted in duplicate. Any result that is significantly different from the control 
(p < 0.05) is indicated with an asterisk. This figure is included with the approval of the 
author, Liong Ka Hang.  
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level as described in 2.2.8. For type II cells derived from both male and female fetuses, 
exposure to heregulin-1β significantly increased the level of β-adrenergic receptor 
(p < 0.05). Moreover, the extent of induction of the β-adrenergic receptor was of similar 
magnitude in male- and female-derived type II cells (Figure 2.11).  
2.3.4 Effect of heregulin-1β on β-agonist stimulation of surfactant 
phospholipid secretion. 
2.3.4.1 Effect of (–)-isoproterenol on surfactant phospholipid secretion. 
Fetal rat type II cells were grown in culture for 3 days prior to the surfactant 
phospholipids being labelled for 24 hours with [
3
H-methyl]-choline chloride. The 
amount of labelled phospholipid secreted into the media during a subsequent 3-hour 
period was 1.4-fold higher in cells exposed to either 0.1 or 1 μM (–)-isoproterenol when 
compared to the control cells incubated with an equivalent volume of vehicle (ascorbic 
acid solution), however, this slightly elevated rate of secretion is not significantly 
different from that seen with control cells (Figure 2.12).   
2.3.4.2 Effect of heregulin-1β pre-treatment on (–)-isoproterenol-induced 
secretion of surfactant phospholipids in type II pneumocytes.   
When type II cells were exposed to 50 ng.mL
-1 
heregulin-1β during the 
period of surfactant phospholipid labelling and subsequently incubated with 1 μM                       
(–)-isoproterenol  the  response to  the β- agonist was significantly greater than that seen 
in cells exposed only to 1 μM (–)-isoproterenol (Figure 2.13). Whereas                         
(–)-isoproterenol only marginally increases the rate of secretion in control cells (1.2-fold) 
it induces a 2.5-fold increase (p < 0.01) if the cells have been previously exposed to 
50 ng.mL
-1
 heregulin-1β. It should be noted that, in those cells exposed to heregulin-1β, 
the peptide was removed by washing of the cells prior to the addition of the                  
(–)-isoproterenol   and   the   commencement   of   the  3-hour   secretory  period.    This                  
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Figure 2.11 Influence of sex on heregulin-1β induction of β-adrenergic 
receptor level in type II pneumocytes. 
Male and female fetuses from 19-day pregnant rats were separated as described in 2.2.1 
and the type II pneumocytes isolated and cultured as described in 2.2.4. The cells were 
grown for 72 hours in MEM
C
 prior to a 24-hour exposure to either 50 ng.mL
-1
 
heregulin-1β in 250 μL of MEM+ ( ) or 250 μL of MEM+ alone (control, ). The cells 
of both sexes were then analysed for β-adrenergic receptor level as described in 2.2.8. 
The results represent the mean ± SEM of 5 separate experiments conducted in duplicate. 
Any result that is significantly different from the control (p < 0.05) is indicated with an 
asterisk.      
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Figure 2.12 Effect of (–)-isoproterenol on surfactant phospholipid secretion.  
Rat type II pneumocytes were isolated from fetal lung tissue and grown in culture for 
3 days as described in 2.2.4. The cells were then exposed to 1.0 μCi.mL-1 [3H-methyl]-
choline chloride in order to label surfactant phospholipids. After 24 h exposure the cells 
were washed three times with 3 mL BSS to remove unincorporated [
3
H-methyl]-choline 
chloride and the media replaced with 1.7 mL of MEM
+ 
and the cells equilibrated for a 
further 1 h prior to the addition of 0.1 and 1 μM (–)-isoproterenol, respectively ( ) or an 
equivalent volume of ascorbic acid solution  (vehicle, ). The amount of labelled 
phospholipid secreted into the media after 3 h of incubation was determined as 
described in 2.2.7.4. The enhanced levels of surfactant secretion in response to 0.1 and 
1.0 μM (–)-isoproterenol were 1.44-fold and 1.41-fold, respectively. The results 
represent the mean ± SEM of 4 separate experiments conducted in duplicate.  
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Figure 2.13 Effect of heregulin-1β on (–)-isoproterenol-induced secretion of 
surfactant phospholipids from type II pneumocyte. 
Rat type II pneumocytes were isolated from fetal lung tissue and grown in culture for 
3 days as described in 2.2.4. The cells were then exposed to 1.0 μCi.mL-1 [3H-methyl]-
choline chloride in order to label surfactant phospholipids and 50 ng.mL
-1
 of 
heregulin-1β. After 24 h exposure the cells were washed three times with 3 mL BSS to 
remove unincorporated [
3
H-methyl]-choline chloride, the media replaced with 1.7 mL 
of MEM
+ and the cells equilibrated for a further 1 h prior to the addition of 1 μM          
(–)-isoproterenol ( ) or an equivalent volume of ascorbic acid solution (vehicle, ). The 
amount of labelled phospholipid secreted into the media after 3 h of incubation was 
determined as described in 2.2.7.4. The results represent the mean ± SEM of 4 separate 
experiments conducted in duplicate. Any result that is significantly different from the 
control (p < 0.01) is indicated with asterisks. 
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stimulatory effect of heregulin-1β on the (–)-isoproterenol-induced secretion of 
surfactant phospholipids from type II cells was equally evident in cells derived from 
male and female rat fetuses (Figure 2.14) and similar to that seen in cultures derived 
from a mixture of male and female fetuses (Figure 2.13).   
2.4 Discussion 
2.4.1 Surfactant phospholipid synthesis in type II cells 
Smith (1978) observed that glucocorticoids had no significant effect on surfactant 
phospholipid production when applied directly to type II epithelial cells. However, if 
lung fibroblasts were pre-conditioned in the presence of glucocorticoids, the 
conditioned media enhanced the rate of phospholipid synthesis in type II cells. They 
proposed that exposing lung fibroblasts to glucocorticoids generated a differentiation 
factor, which they called fibroblast pneumocyte factor (FPF). This factor, which was 
later shown to be a peptide, has a molecular weight of 5-15 kDa (Smith, 1979). 
Numerous attempts have  been  made to identify FPF. Torday and  Kourembanas (1990) 
and McDevitt et al. (2007) observed that glucocorticoids reduce the expression of 
TGF-β, an agent which is known to suppress the production of surfactant phospholipids. 
Torday et al. (2002), and subsequently Kirwin et al. (2006), provided evidence that 
leptin,  which  is  expressed by lipofibroblasts during rat lung development, has many of 
the characteristics of FPF. More recently, Dammann et al. (2003) observed  that  
neuregulin-1β  is able to mimic  the  effect of  FPF  and  that  the stimulatory effect of 
FCM can be blocked by pre-treatment with a neuregulin-1β antibody. Despite these 
numerous attempts to identify FPF its chemical nature is still not definitively known.  
 In agreement with Smith (1978), Maker (2008) also demonstrated that 
dexamethasone does not have a stimulatory effect on surfactant phospholipid synthesis 
when applied directly to type II cells but does so if cultured lung fibroblasts are exposed  
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Figure 2.14 Influence of sex of donor animal on the heregulin-1β stimulation of 
(–)-isoproterenol-induced secretion of surfactant phospholipids. 
Fetal rats were separated into male and female groups and then type II cells were 
isolated from their lungs and grown in culture for 3 days as described in 2.2.4. The cells 
were then exposed to 1.0 μCi.mL-1 [3H-methyl]-choline chloride, in order to label 
surfactant phospholipids, and 50 ng.mL
-1
 of heregulin-1β. After 24 h exposure the cells 
were washed three times with 3 mL BSS to remove unincorporated [
3
H-methyl]-choline 
chloride and the media replaced with 1.7 mL of MEM
+ 
and the cells equilibrated for a 
further 1 h prior to the addition of 1 μM (–)-isoproterenol ( ) or an equivalent volume 
of ascorbic acid solution (vehicle, ). The amount of labelled phospholipid secreted into 
the media after 3 h of incubation was determined as described in 2.2.7.4. The results 
represent the mean ± SEM of 3 separate experiments conducted in duplicate. Any result 
that is significantly different from its corresponding control (p < 0.01) is indicated with 
asterisks. 
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to dexamethasone and the FCM generated under these conditions incubated with the 
type II cells. Furthermore, using liquid chromatography-mass spectrometry, he showed 
that FCM generated in the presence of dexamethasone had a higher concentration of 
neuregulin-1β than that generated in the absence of the steroid, suggesting that 
neuregulin-1β has, at least, some of the attributes of FPF. 
  The current study has shown that surfactant phospholipid synthesis 
increased over time when type II cells were exposed to 50 ng.mL
-1
 heregulin-1β, 
compared to the corresponding control (Figure 2.4). This linear increase in the 
incorporation of [
3
H]-choline into surfactant phospholipids is in agreement with 
previous findings from this laboratory that radiolabelled phospholipids continue to 
accumulate within type II cells until approximately 10 hours, when secretion of 
radiolabelled surfactant phospholipids begins to occur (data not shown). The result is 
also similar to that observed by Post et al. (1986), who showed that there was an 
elevated rate of incorporation of [
3
H]-choline into phosphatidylcholine when type II 
cells were incubated with purified fibroblast pneumocyte factor, although the latter 
study was conducted over a shorter period of time.  
 In type II cells exposed to heregulin-1β for six hours over the range 10 to 
200 ng.mL
-1
, surfactant phospholipid synthesis was enhanced at all concentrations, but 
was only significant at 20 and 50 ng.mL
-1
 heregulin-1β compared to the corresponding 
control (p < 0.05; Figure 2.5). It is possible that, at 10 ng.mL
-1
, the ligand concentration 
was insufficient to saturate the ErbB receptors, whereas at 100 and 200 ng.mL
-1
, the 
high concentration of the ligand led to down-regulation of the ErbB receptor. Although 
the mechanism by which this down-regulation occurs in type II cells is unknown, Cao et 
al. (2007) have shown that neuregulin induces both ubiquitination and degradation of 
the ErbB3 receptor in MCF-7 breast cancer cells. If neuregulin-induced degradation of 
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the ErbB receptor also occurs in type II cells this could explain the decline in the 
response to higher concentrations of the ligand. The enhanced rate of phospholipid 
synthesis in type II cells exposed to neuregulin-1β is in agreement with the observation 
of Dammann et al. (2003) that an antibody to neuregulin-1β was able to completely 
eliminate the stimulatory effect of FCM on surfactant phospholipid synthesis.  
 Since Torday et al. (2002) have previously shown that leptin was induced in 
lung fibroblasts exposed to dexamethasone and that leptin enhanced phospholipid 
synthesis when applied directly to type II cells, a comparison was made between the 
extent of induction of phospholipid synthesis by leptin and neuregulin-1β. Leptin-
treated type II cells showed a significant increase in surfactant phospholipid synthesis 
when exposed to 20 and 50 ng.mL
-1
 of the ligand for four hours, compared to the 
control (p < 0.05 and p < 0.01, respectively) (Figure 2.6). There was also an increase 
when type II cells were treated with 100 ng.mL
-1
 leptin, but this was not significant 
(p > 0.05). Applying the same argument that was used to explain the optimal 
concentration for heregulin-1β, it is possible that 20-50 ng.mL-1 leptin is the optimal 
concentration range required to activate leptin receptors. Unlike its effect at six hours, 
50 ng.mL
-1
 heregulin-1β did not significantly increase phospholipid synthesis if the 
exposure time was only four hours, which suggests that the cells require a longer period 
of exposure to heregulin-1β than to leptin.  
2.4.2 Surfactant phospholipid secretion from type II cells  
 When the rate of secretion of surfactant phospholipids from the type II cells 
was examined, there was an almost linear increase in the amount of radiolabelled 
phospholipids secreted under control conditions for up to three hours. In comparison, 
the rate of surfactant phospholipid secretion was elevated if the cells were exposed 
to 50 ng.mL
-1
 heregulin-1β (Figure 2.7). If the cells were exposed to heregulin-1β over 
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the range 10 to 200 ng.mL
-1
 for three hours, secretion was elevated at all concentrations 
but was only significantly different (p < 0.05) from the control rate of secretion at a 
heregulin-1β concentration of 50 ng.mL-1 (Figure 2.8). It is possible at the lower 
concentrations the ErbB receptors are insufficiently activated to promote the 
morphological changes required for type II cells to secrete pulmonary surfactant 
(Crovello et al., 1998). Zhao et al.(1998) have shown that the related peptide, 
recombinant human GGF2 (rhGGF2), which also has its effect via ErbB receptors, 
enhances embryonic cardiac myocyte proliferation through an elevated rate of 
thymidine uptake. Similar to the response to heregulin-1β, as reported in this thesis, the 
effect of rhGGF2 was maximal at a concentration of 30 ng.mL
-1
 and there was a 
decrease in the response at higher concentrations. 
 Leptin treatment of type II cells at 20, 50 or 100 ng.mL
-1
 did not bring about 
any significant change in the level of surfactant phospholipid secretion (Figure 2.9). 
This finding shows that, whereas leptin stimulates the synthesis of surfactant 
phospholipids in type II cells (Torday and Rehan, 2002; Torday et al., 2002; Kirwin et 
al., 2006), it has no effect on the rate at which surfactant is secreted from these cells. 
This is in contrast to the finding that 50 ng.mL
-1
 heregulin-1β stimulates both synthesis 
and secretion of the surfactant phospholipids (Figures 2.5 and 2.8). 
2.4.3 Influence of sex on heregulin-1β induction of β-AR in type II 
pneumocytes  
 Exposure of type II cells to 50 and 100 ng.mL
-1
 heregulin-1β for 24 hours 
has previously been shown to significantly increase the β-AR level, compared to that in 
control cells (p < 0.05; Figure 2.10). The present study has shown that, irrespective of 
the gender from which the fetal type II cells were derived, exposure of these cells to 
heregulin-1β resulted in an enhanced level of β-adrenergic receptors (Figure 2.11). 
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FCM generated in the presence of dexamethasone has previously been shown to 
enhance the β-AR activity more if the cells were derived from female instead of male 
fetuses (Damas, 2010). This suggests that male-derived fibroblasts produce a lower 
concentration of FPF in response to dexamethasone than those derived from females. 
Given that neuregulin-1β may be FPF (or at least a component of it), the current study 
examined the ability of neuregulin-1β to enhance the β-AR activity in cells derived from 
either male or female fetal lungs. It was observed that the neuregulin-1β-induced 
activity of β-AR was the same in cells derived from either sex. This observation, 
together with the previous finding of Damas (Damas, 2010) that there is a sex-linked 
difference in the induction of β-AR by media conditioned by fibroblasts in the presence 
of dexamethasone, suggests that the latter difference is an attribute of the lung 
fibroblasts, a suggestion which is consistent with the previous conclusion of Torday et 
al. (1984). 
2.4.4 Effect of heregulin-1β on β-agonist stimulation of surfactant secretion 
 The rate of secretion of surfactant phospholipid from type II cells after 
exposure to 1 μM (–)-isoproterenol was slightly elevated, although this increase was not 
significantly different from the control (Figure 2.12). When type II cells were treated 
with 50 ng.mL
-1
 heregulin-1β for 24 hours prior to exposure to (–)-isoproterenol, there 
was a significant increase in the level of surfactant secretion from the cells (p < 0.01) 
(Figure 2.13). This finding is consistent with the observation that heregulin-1β 
increased β-AR expression in type II cells, which would be expected to enhance the 
ability of the cells to respond to (–)-isoproterenol. Several investigators have previously 
shown that (–)-isoproterenol stimulates surfactant phospholipid secretion from lung 
epithelial cells (Dobbs and Mason (1979); Ormond et al., 2003; Abrahama et al., 2004 
and Shi et al. (2011) but, to my knowledge, this is the first time that the response to     
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(–)-isoproterenol has been shown to be modulated by heregulin-1β. This heregulin-1β-
induced elevation in the response to (–)-isoproterenol was equally evident if the type II 
cells were isolated from female or male fetuses (Figure 2.14). This further supports the 
conclusion that there is no influence of sex on the level of β-AR or β-agonist-induced 
secretion of surfactant phospholipids from fetal type II pneumocytes. 
 
 
 
 
 
  
 
 
Chapter 3 
Regulation of expression of the neuregulin-1β gene and the 
β-adrenergic receptor gene in cultured fetal lung cells 
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3.1 Introduction  
3.1.1 Role of neuregulin-β in the response of type II cells to glucocorticoids   
Since the pioneering work of Liggins (1969), who demonstrated that 
glucocorticoids induce precocious maturation of the lung, Smith (1978) has shown that 
this is an indirect effect resulting from the production of fibroblast pneumocyte factor 
(FPF) by lung fibroblasts. Subsequently, this release of FPF has also been shown to be 
elevated if these cells are exposed to EGF (Nielsen, 1989; Sen and Cake, 1991). Work 
by Dammann et al. (2003), together with the findings presented in Chapter 2 of this 
study, suggest that neuregulin-1β is a strong candidate for being FPF, or at least a major 
component of FPF. This suggestion is supported by the observation that the 
concentration of neuregulin-1β in media conditioned by cultured lung fibroblasts in the 
presence of dexamethasone is increased 2-fold (Maker, 2008). If this is the case, then 
exposure of lung fibroblasts to either glucocorticoids or EGF would be expected to 
increase the level of neuregulin-1β mRNA, which is likely to be the consequence of 
elevated transcription of the neuregulin-1β gene. 
Nielsen, Dammann and their co-workers have previously shown that the 
ErbB receptor family, which includes ErbB1, ErbB2, ErbB3 and ErbB4, and their 
ligands EGF and neuregulin-1 have a profound influence on the differentiation and 
maturation of the lung (Dammann et al., 2003). All four ErbB receptors are known to be 
present in type II cells and have distinct dimerization patterns (Zscheppang et al., 2006; 
Liu et al., 2007; Zscheppang et al., 2007). In mouse type II cells, ErbB1-ErbB4 and 
ErbB2-ErbB3 were the most common dimerization pairs and treatment of the cells with 
neuregulin-1 resulted in enhanced phosphorylation of the tyrosine residues associated 
with ErbB1 and ErbB2 (Zscheppang et al., 2006; Liu et al., 2007). Subsequent work by 
this research group has identified ErbB4 as an important receptor in the maturation of 
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fetal rat type II cells (Zscheppang et al., 2007), and maintenance of surfactant synthesis 
in adult rat type II cells (Liu et al., 2009).  
3.1.2 Role of neuregulin-1 in the glucocorticoid induction of β-adrenergic 
receptors and the response of type II cells to β-agonists  
For a long time it has been known that glucocorticoids stimulate an increase 
in the pulmonary β-adrenergic receptor level in a diversity of species, including rabbits 
(Cheng et al., 1980; Giannopoulos and Sommers Smith, 1982), rats (Maniscalco and 
Shapiro, 1983; McGraw et al., 1995) and mice (Slieker et al., 1995). Glucocorticoids 
are lipid-soluble hormones which can penetrate the membrane of target lung cells where 
they interact with their specific intracellular receptors inducing genomic effects via 
direct DNA binding or transcription factor inactivation (Van der Velden, 1998; 
Alangari, 2010). The latter author also suggested that some of the effects of 
glucocorticoids may be the result of non-genomic actions involving interactions with 
cell membranes or membrane-bound receptors. Mak et al. (1995a) have shown that 
treatment of human lung tissue with dexamethasone increased both the β-adrenergic 
receptor density and the level of β-AR mRNA, implying that the steroid has its effect 
through increased transcription of the β-AR gene. It was subsequently reported that 
there is a glucocorticoid response element (GRE) located at position -379 to -365 in the 
5’-flanking region of the rat β-AR gene (Cornett et al., 1998).  
Although it is clear from the above that glucocorticoids are able to directly 
activate transcription of the β-AR gene in type II pneumocytes, it is possible that these 
steroids may also regulate the level of β-AR via the action of FPF. The latter suggestion 
comes from the observation that media conditioned by fibroblasts in the presence of 
dexamethasone induces a higher β-AR density if the fibroblasts are derived from female 
rather than male fetal rat lungs (Damas, 2010). This implies that this effect of 
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glucocorticoids might also involve the production of FPF, levels of which are known to 
be higher if the fibroblasts are derived from female animals (Torday, 1984). Given that 
neuregulin-1β might be one of the active agents of FPF (see 3.1.1), this study tested the 
hypothesis that the direct exposure of type II cells to recombinant human neuregulin-1β 
(heregulin-1β) will either increase transcription of the β-AR gene or act synergistically 
with dexamethasone to enhance the expression of this gene.  
In the current study, qPCR was used to ascertain whether the elevated levels 
of neuregulin-1β in media conditioned by lung fibroblasts in the presence of 
dexamethasone was the result of enhanced transcription of the neuregulin-1β gene. In 
addition, the same technique was employed to determine whether the rate of 
transcription of the β-AR gene was increased if lung type II cells were exposed to 
heregulin-1β. This effect was examined at different time intervals for three different 
concentrations of heregulin-1β in both the presence and absence of 50 nM 
dexamethasone.     
3.2 Materials and methods  
3.2.1 Materials 
 SYBR Green (Invitrogen), which was used in early experiments, was 
generously provided by Dr. David Berryman, Murdoch University. SYBR Safe DNA 
gel stain was obtained from Invitrogen, Eugene, OR, USA. Primers and TaqMan probes 
were obtained from Integrated DNA Technology, Coralville, IA, USA. The SV total 
RNA isolation system and RNase ONE ribonuclease were purchased from Promega 
Corporation, Madison, WI, USA. The OneStep RT-PCR kit used for PCR reactions was 
purchased from Qiagen Sciences, Germantown, MD, USA. Agarose and DTT were 
purchased from Fisher Biotec, Perth, Western Australia.  
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3.2.2 Fibroblast cultures for RNA extraction  
 Fibroblast cells derived from day 19 fetal rat lungs were isolated as 
described in 2.2.4. After cell growth in MEM
C
 for at least 8 days, with a media change 
every other day, the plates were considered confluent with fibroblast cells and free from 
type II cell contamination. The media was removed from the plates and the cells washed 
twice with 2 mL of warm BSS. To each plate was then added 3 mL of MEM
+
 
containing 30 μL of either dexamethasone in propylene glycol (to yield a final 
dexamethasone concentration of either 20 or 50 nM) or propylene glycol (control), and 
returned to the incubator. To establish a time course, these additions were made 4, 6, 8 
and 24 hours before the cells were harvested.   
3.2.3 Type II pneumocyte cultures for RNA extraction  
 Type II cells derived from day 19 fetal rat lungs were isolated as described 
in 2.2.4. After cell growth in MEM
C
 for 3 days, with a media change after one day in 
culture, the media was removed from the plates and the cells washed twice with 2 mL of 
warm BSS. To each plate was then added 3 mL of MEM
+
 containing 30 μL of either 
heregulin-1β (to yield a final concentration of 20, 50 or 100 ng.mL-1) or water as 
control. In some experiments the cells were simultaneously exposed to the above 
concentrations of heregulin-1β with either 50 nM dexamethasone or an equivalent 
volume of propylene glycol. To establish a time course, these additions were made 2, 4, 
6 and 8 hours before cell harvest.   
3.2.4  RNA extraction 
3.2.4.1 Cell harvesting  
 Sterile techniques were adhered to at all times during harvesting. After the 
fibroblast cells had been incubated as indicated, plates were removed from the incubator 
and the media discarded. The plates were washed 3 times with warm BSS and the cells 
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transferred to sterile tubes using two additions of 1 mL of BSS and a cell scraper. The 
combined cell extracts were diluted to 25 mL with BSS and centrifuged at 1000 g for 5 
minutes. The supernatant was discarded. 
3.2.4.2  Extraction procedure  
 Total RNA from the cell pellet was extracted using the protocol for the SV 
Total RNA Isolation System (Promega Corporation, Madison, WI, USA). An 
Eppendorf 5417C microcentrifuge (Eppendorf AG, Hamburg, Germany) was used for 
all centrifugation steps. All pipette tips and microcentrifuge tubes used were certified 
nuclease-free. Following extraction, RNA extracts were stored at -70°C until 
quantification.  
3.2.4.3  RNA quantification 
 The extracted RNA was quantified using an Agilent 2100 Bioanalyzer with 
an Agilent RNA 6000 Pico kit (Agilent Technologies Inc., Santa Clara, CA, USA). 
Prior to use, the extracts were thawed and, when necessary, diluted with RNase-free 
water to give a mRNA concentration in the range 400-5000 pg.μL-1. An appropriate 
aliquot of this solution was added to the RT-PCR such that the final amount of mRNA 
in each reaction was 5 ng.     
3.2.5  Design of RT-PCR primers and probes   
 To design RT-PCR primers and probes for GAPDH, neuregulin-1β, TGF-β 
and β-AR genes, an NCBI GenBank search of the cDNA and genomic DNA sequences 
for these genes was performed on Rattus norvegicus chromosome 4 for GAPDH, 
chromosome 16 for neuregulin-1β, chromosome 1 for TGF-β and chromosome 18 for 
β-AR. The RT-PCR primers for GAPDH and TGF-β mRNA quantification were 
designed to include a splice junction between the forward and reverse primers thereby 
providing the means of distinguishing between the products of mRNA and genomic 
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DNA based on the size of the product. The reverse primer for neuregulin-1β spanned 
across a splice junction thus eliminating any contribution by possible genomic DNA 
contamination. Each of the primer sequences chosen were checked for melting 
temperature (TM) using Primer3 software, absence of cross reactivity with other 
sequences (using BLAST software) and neither primer dimer formation nor interference 
with reference gene primers in a multiplex reaction, as was evident from agarose 
electrophoresis of the RT-PCR products. The base sequence of GAPDH, neuregulin-1β, 
TGF-β and β-AR cDNA, highlighting the primer binding sequences, are shown in 
Figures 3.1, 3.2, 3.3 and 3.4, respectively. The forward and reverse primer sequences 
chosen for GAPDH, neuregulin-1β, TGF-β and β-AR are shown in Table 3.1. The 
primer sequences for Pgk, Rpl13a, ACTB, Ppia and Tfrc, which were obtained 
commercially as a rat housekeeping gene primer set (Real Time Primers, Elkins Park, 
PA, USA), are also shown in Table 3.1.  
A similar rationale was used to design the TaqMan probes except that their 
melting temperatures were approximately 10ᵒC higher than either of the forward and 
reverse primers. The probes for GAPDH, neuregulin-1β, TGF-β and β-AR were 
designed with Iowa Black® quencher at the 3’ end and  the FAM (green), Cy5 (red), 
HEX (yellow) and HEX (yellow) reporter dyes  covalently  attached  at the 5’  end,  
respectively,  to  allow  the  different  PCR products to be distinguished. The sequence 
of these probes is shown in Table 3.2. 
3.2.6 β-AR primers and test for specificity   
 Because the β-AR gene has no introns and therefore does not contain splice 
junctions (Emorine et al., 1987; Kobilka et al., 1987; Chatterjee et al., 1997; Aksoy et 
al., 2002), the PCR product could theoretically be derived from either mRNA or 
contaminating  genomic  DNA. To  confirm that  the  RNA  extraction procedure, which 
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NCBI Reference Sequence: NM_017008 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH), cDNA - Rattus norvegicus (chromosome 4) 
 
gggggctctctgctcctccctgttctagagacagccgcatcttcttgtgcagtgccagcctcgtctcata
gacaagatggtgaaggtcggtgtgaacggatttggccgtatcggacgcctggttaccagggctgccttct
cttgtgacaaagtggacattgttgccatcaacgaccccttcattgacctcaactacatggtctacatgtt
ccagtatgactctacccacggcaagttcaacggcacagtcaaggctgagaatgggaagctggtcatcaac
gggaaacccatcaccatcttccaggagcgagatcccgctaacatcaaatggggtgatgctggtgctgagt
atgtcgtggagtctactggcgtcttcaccaccatggagaaggctggggctcacctgaagggtggggccaa
aagggtcatcatctccgccccttccgctgatgcccccatgtttgtgatgggtgtgaaccacgagaaatat
gacaactccctcaagattgtcagcaatgcatcctgcaccaccaactgcttagcccccctggccaaggtca
tccatgacaactttggcatcgtggaagggctcatgaccacagtccatgccatcactgccactcagaagac
tgtggatggcccctctggaaagctgtggcgtgatggccgtggggcagcccagaacatcatccctgcatcc
actggtgctgccaaggctgtgggcaaggtcatcccagagctgaacgggaagctcactggcatggccttcc
gtgttcctacccccaatgtatccgttgtggatctgacatgccgcctggagaaacctgccaagtatgatga
catcaagaaggtggtgaagcaggcggccgagggcccactaaagggcatcctgggctacactgaggaccag
gttgtctcctgtgacttcaacagcaactcccattcttccacctttgatgctggggctggcattgctctca
atgacaactttgtgaagctcatttcctggtatgacaatgaatatggctacagcaacagggtggtggacct
catggcctacatggcctccaaggagtaagaaaccctggaccacccagcccagcaaggatactgagagcaa
gagagaggccctcagttgctgaggagtccccatcccaactcagcccccaacactgagcatctccctcaca
attccatcccagaccccataacaacaggaggggcctggggagccctcccttctctcgaataccatcaata
aagttcgctgcaccctcaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa 
 
 
Figure 3.1 Base sequence of the rat glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) cDNA.  
The start and stop codons are highlighted in aqua and purple, respectively, and the 
sequences in blue correspond to the untranslated regions. The underlined sequences are 
the primer binding sites for the forward and reverse primers. The sequence highlighted 
in green corresponds to the binding site for the fam-tagged TaqMan probe for GAPDH 
cDNA, which was used in all multiplex qPCR analyses. Those bases highlighted in grey 
represent a splice junction.  
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NCBI Reference Sequence: NM_031588.1 
Neuregulin-1β, cDNA - Rattus norvegicus (rat chromosome 16) 
gcggccgcagctgccgggagatgcgagcgcagaccggattgtgatcacctttccctcttcgggctgtaag
agagcgagacaagccaccgaagcgaggccactccagagccggcagcggagggacccgggacactagagca
gctccgagccactccagactgagcggacgctccaggtgatcgagtccacgctgcttcctgcaggcgacag
gcgacgcctcccgagcagcccggccactggctcttcccctcctgggacaaacttttctgcaagcccttgg
accaaacttgtcgcgcgtcaccgtcacccaaccgggtccgcgtagagcgctcatcttcggcgagatgtct
gagcgcaaagaaggcagaggcaaggggaagggcaagaagaaggaccggggatcccgcgggaagcccgggc
ccgccgagggcgacccgagcccagcactgcctcccagattgaaagaaatgaagagccaggagtcagctgc
aggctccaagctagtgctccggtgcgaaaccagctccgagtactcctcactcagattcaaatggttcaag
aatgggaacgagctgaaccgcaaaaataaaccagaaaacatcaagatacagaagaagccagggaagtcag
agcttcgaattaacaaagcatccctggctgactctggagagtatatgtgcaaagtgatcagcaagttagg
aaatgacagtgcctctgccaacatcaccattgttgagtcaaacgagttcatcactggcatgccagcctcg
actgagacagcctatgtgtcctcagagtctcccattagaatctcagtttcaacagaaggcgcaaacactt
cttcatccacatcaacatccacgactgggaccagccatctcataaagtgtgcggagaaggagaaaacttt
ctgtgtgaatgggggcgagtgcttcacggtgaaggacctgtcaaacccgtcaagatacttgtgcaagtgc
ccaaatgagtttactggtgatcgttgccaaaactacgtaatggccagcttctacaaagcggaggaactct
accagaagagggtgctgacaattactggcatctgtatcgccctgctggtggtcggcatcatgtgtgtggt
ggcctactgcaaaaccaagaagcagcggcagaagcttcatgatcggcttcggcagagtcttcggtcagaa
cggagcaacctggtgaacatagcgaatgggcctcaccacccaaacccaccgccagagaacgtgcagctgg
tgaatcaatacgtatctaaaaacgtcatctccagtgagcatattgttgagagagaagtggagacttcctt
ttccaccagtcattacacttccacagcccatcactccacgactgtcacccagactcctagtcacagctgg
agtaatgggcacacggagagcgtcatttcagaaagcaactccgtaatcatgatgtcttcggtagagaaca
gcaggcacagcagtcccgccgggggcccacgaggacgtcttcatggcctgggaggccctcgtgataacag
cttcctcaggcatgccagagaaacccctgactcctacagagactctcctcatagcgaaaggtatgtatca
gccatgaccaccccggctcgtatgtcacctgtagatttccacacgccaagctcccctaaatcgccccctt
cggaaatgtctccacccgtgtccagcatgacggtgtccatgccctctgtggcagtcagcccctttgtgga
agaagagaggcctctgctgcttgtgacgccaccaaggctacgggagaagaaatatgatcatcacccccag
caactcaactcctttcatcacaaccctgcacatcagagtaccagcctcccccctagcccactgaggatag
tggaggatgaggagtacgagacgacccaggagtatgagtcagttcaagagcccgttaagaaagtcaccaa
tagccggcgggccaaaagaaccaagcccaatggccacattgccaataggttggaaatggacagcaacaca
agttctgtgagcagtaactcagaaagtgagacagaagacgaaagagtaggtgaagacacaccattcctgg
gcatacagaaccccctggcagccagccttgaggtggcccctgccttccgtctggctgagagcaggactaa
cccagcaggccgcttctccacacaggaggaattacaggccaggctgtctagtgtaatcgctaaccaagac
cctattgctgtataaaacctaaataaacacatagattcacctgtaaaactttattttatataataaagta
tttcaccttaaattaaacaatttattttattttagcagttctgcaaatagaaaacaggaagaaaaaaaaa
cttttataaattaaatatatgtatgtaaaaatgtgttatgtgccatatgtagcaatttttttacagtatt
tcaaaaacgagaaagatatcaatggtgcctttatgttctgttatgtcgagagcaagttttataaagttat
ggtgatttctttttcacagtatttcagcaaaacctcccatatattcagtttctgctggctttttgtgcat
tgcattatgatgttgactggatgtatggtttgcaaggctagcagctcgctcgtgttctctctctctctct
ctctctctctctctctgtctctctctctgtctctctctctctctctctctctctctctctctctctctct
ctctctctctctctgtctctctctctgcttcccgtagctcccaaccagtactgtcttggactggcacatc
catccaaatacctttctactttgtatgaagttttctttgctttcccaatatgaaatgagttctctctact
ctgtcagccaaaggtttgcttcactggactctgagataatagtagacccagcagcatgctactattacgt
atagcaggaaactgcaccaagtaatgtccaataataggaagaaagtaatactgtgatttaaaaaaaaaaa
caaactatattattaatcagaagacagcttgctcttggtaaaaggagctaccattgactctaattttgac
tttttagttattgttcttgacaaagagtaacagcttcaagtacagcctagaaaaaaaaatgggttctggc
ctgctatcaggataaatctatcgacgtagatagattcaactcagtttcactttctgtcttgggggaaatg
atccagccactcatatgacgaccaaccaaccacaggtgcctctgctccctgt 
Figure 3.2 Base sequence of the rat neuregulin-1β (NRG-1β) cDNA.  
The start and stop codons are highlighted in aqua and purple, respectively, and the sequences in 
blue correspond to untranslated regions. The underlined sequences are the primer binding sites 
for the forward and reverse primers. The sequence highlighted in red corresponds to the binding 
site for the cy5-tagged TaqMan probe for NRG-1β cDNA, which was used in all multiplex 
qPCR analyses. Those bases highlighted in grey represent a splice junction. Prior to the adenine 
labelled in red type the sequence gcatcttgggattgaatttatgga, which is found in both of the genes 
coding for rat GGF and human neuregulin, is missing from the rat neuregulin-1β gene. 
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NCBI Reference Sequence: NM_021578 + BC076380 
Transforming growth factor (TGF-β), cDNA - Rattus norvegicus (rat chromosome 1) 
 
ccgcctcccgcaaagacttcaccccaaagctggggcgcaccccttgcacgccaccctccccccagcctg
cttcttgagtcccccgcatcccaggaccctctctcctctgggaggccgatctccctcggacctgctggc
aatagcttcctatttaagaacaccccacttttgggtcccagagagcgctcatctcgatttttatcccgg
tggcatactgagacactctggtgtcagagcgtcaccgcgactcctgctgctttctccctcaacctcaaa
ttattcaggactatcacctacctttccttgggagaccccaccccaccccacaagccctgcaggggcggg
gcctccgcatcccacctttgcccggggttcgcgctctccgaagttccgtggggcgccgcctcccccatg
ccgccctcggggctgcggctgctgccgcttctgctcccactcccgtggcttctagtgctgacgcccggg
aggccagccgcgggactctccacctgcaagaccatcgacatggagctggtgaaacggaagcgcatcgaa
gccatccgtggccagatcctgtccaaactaaggctcgccagtcccccgagccagggggaggtaccgccg
ggcccgctgcccgaggcggtgctcgctttgtacaacagcacccgcgaccgggtggcaggcgagagcgct
gacccggagcccgagcccgaggcggactactacgccaaagaagtcacccgcgtgctaatggtggaccgc
aacaacgcaatctatgacaaaaccaaagacatcacacacagtatatatatgttcttcaatacgtcagac
attcgggaagcagtgccagaacccccattgctgtcccgtgcagagctgcgcctgcagagattcaagtca
actgtggagcaacacgtagaactctaccagaaatatagcaacaattcctggcgttaccttggtaaccgg
ctgctgacccccactgatacgcctgagtggctgtcttttgacgtcactggagttgtccggcagtggctg
aaccaaggagacggaatacagggctttcgcttcagtgctcactgctcttgtgacagcaaagataatgta
ctccacgtggaaatcaatgggatcagtcccaaacgtcgaggtgacctgggcaccatccatgacatgaac
cgacccttcctgctcctcatggccacccccctggaaagggctcaacacctgcacagctccaggcaccgg
agagccctggataccaactactgcttcagctccacagagaagaactgctgtgtacggcagctgtacatt
gactttaggaaggacctgggttggaagtggatccacgagcccaagggctaccatgccaacttctgtctg
gggccctgcccctacatttggagcctggacacacagtacagcaaggtccttgccctctacaaccaacac
aacccgggtgcttccgcatcaccgtgctgcgtgccgcaggctttggagccactgcccatcgtctactac
gtgggtcgcaagcccaaggtggagcagttgtccaacatgatcgtgcgctcctgcaagtgcagctgaggc
cccgcccccgccccgccccgcccctcccggcaggcccggccccgcccccgccccgcccgcagtgcccgg
ggctgtatttaaggacacctgcaccccccccaagcccatctgggggcccattaaaggtgacagaggaaa
aaaaaaaaaaaaaaaaaaaaaaa 
 
Figure 3.3 Base sequence of the rat TGF-β cDNA.  
The start and stop codons are highlighted in aqua and purple, respectively, and the 
sequences in blue correspond to the untranslated regions. The underlined sequences are 
the primer binding sites for the forward and reverse primers. The sequence highlighted 
in yellow corresponds to the binding site for the hex-tagged TaqMan probe for TGF-β 
cDNA, which was used in all multiplex qPCR analyses. Those bases highlighted in grey 
represent a splice junction.  
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NCBI Reference Sequence: NM_012492.2 
β- Adrenergic receptor, cDNA - Rattus norvegicus (rat chromosome 18) 
 
cgcgttcaggctgcagctggcaggcatcgcgagcccggagcacccacgagctcagtgtgcaggacgcgc
ccccagcacagccacctacggtctctgaatgaagcttccaggagtccgcccccggacggctgcgcccca
tcggaggtgcacccgctgagagcgtctgggcactgaaagccggtgcgctcacctgccggccatggagcc
acacgggaatgacagcgacttcttgctggcacccaatggaagccgagcgccaggccacgacatcactca
ggaacgggacgaagcgtgggtggtgggcatggccatcctcatgtcggttatcgtcctggccatcgtgtt
tggcaacgtgctggtcatcacagccattgccaagttcgagcgactacaaaccgtcaccaactacttcat
aacctccttggcgtgtgctgatctagtcatgggcctagcggtggtgccttttggggccagtcatatcct
tatgaaaatgtggaattttggcaatttctggtgcgagttctggacttccattgatgtgttgtgcgtcac
agccagcatcgagaccctgtgcgtgattgcagtggatcgctatgttgctatcacatcgcccttcaagta
ccagagcctgctgaccaagaataaggcccgagtggtcatcctaatggtgtggattgtgtcgggccttac
ctccttcttgcctatccagatgcactggtaccgtgccacccacaagcaagccatcgactgttatgccaa
ggagacttgctgtgacttcttcacgaaccaggcctatgctatcgcttcctctatcgtatctttctacgt
gcccctggtggtcatggtctttgtctattccagggtcttccaggtggccaaaaggcagctgcagaagat
agacaaatccgagggcagatttcatgcccaaaacctcagccaggtggagcaggatgggaggagcgggca
cggactccgaaggtcctccaagttctgcttgaaagagcacaaagccctcaagactttaggcatcatcat
gggcaccttcaccctctgctggctgcccttcttcattgtcaatattgtccacgtcatccgggccaacct
catccctaaggaagtttacatcctccttaactggttgggctatgtcaactctgccttcaatcctcttat
ctactgtcggagtccagatttcaggattgccttccaggagcttctgtgccttcgccggtcttcttcgaa
aacctatgggaacggctactctagcaacagcaacggtaggacagactacacaggggagcagagcgcata
tcagctggggcaggagaaagaaaatgaactgctttgtgaggaagcccctggcatggaaggctttgtgaa
ctgtcaaggtactgtgcctagccttagcattgactctcaagggaggaactgtaacacaaacgactcgcc
actgtagtgtaggctttctactctttaagacggcccctccctgacaggacactaaccagactattttac
ttgagtgtaataactttagaataaaattgtatagagattttgcagaaggggcacatccttctgcctttt
ttattttatttttttaagctgcaagtgagagagagagggagagagagagagagagagagagagaaagag
agagagagagactgtatttcagtgcttaatgttttccttgtacagttcagttcctctttgcatggaact
taaaagtttctgtctgaagtgttgttggtctgtctgtttggatggtgtttccatgtatctacctcactg
gtcaagtattaaggataatatatatatatattgctgctggaaattcatatgtaaaggagagagttttct
tcctgtacccttggacttgaaatatcctgtgtcttggacctttctgctgtgaatgtggactctctctca
ctccacttattcgctcaaatggagtgttgtaggcagggatttgagggacaacatcagttgtttttctga
gcaaagtctaaagtttacagtaaataaattgtttgaccatgaaaaaaaaaaaaaaaaaaaaaaa 
 
 
Figure 3.4 Base sequence of the rat β-adrenergic receptor (β-AR) cDNA. 
 
The start and stop codons are highlighted in aqua and purple, respectively, and the 
sequences in blue correspond to the untranslated regions. The underlined sequences are 
the primer binding sites for the forward and reverse primers. The sequence highlighted 
in yellow corresponds to the binding site for the hex-tagged TaqMan probe for β-AR 
cDNA, which was used in all multiplex qPCR analyses.  
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Table 3.1 Forward and reverse primer sequences used in the RT-PCR 
analyses of GAPDH, neuregulin-1β, TGF-β and β-AR. 
 
Primer Size (bp) Forward primer sequence Reverse primer sequence 
GAPDH 207 5’-agacagccgcatcttcttgt-3’ 5’-cttgccgtgggtagagtcat-3’ 
NRG-1β 196 5’-acgactgggaccagccatc-3’ 5’-tctggtagagttcctccgctttg-3’ 
TGF-β 392 5’-gccagatcctgtccaaactaag-3’ 5’-gtaacgccaggaattgttgc-3’ 
β-AR 152 5’-ggagacttgctgtgacttctt-3’ 5’-cctcggatttgtctatcttctg-3’ 
Pgk 253 5’-taaagtcagccatgtgagca-3’ 5’-atgaatcccgatgcagtaaa-3’ 
Rpl13a 242 5’-gtgagggcatcaacatttct-3’ 5’-catccgctttttcttgtcat-3’ 
ACTB 272 5’-cacactgtgcccatctatga-3’ 5’-ccgatagtgatgacctgacc-3’ 
Ppia 295 5’-ctggtggcaagtccatctac-3’ 5’-cccgcaagtcaaagaaatta-3’ 
Tfrc 242 5’-catctccatctgaccctcac-3’ 5’-gtctttggcttctggtgtca-3’ 
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Table 3.2  Probe sequences used in the qPCR analyses of GAPDH, 
neuregulin-1β, TGF-β and β-AR.  
 
 
Probe Dye TaqMan probe sequence 
GAPDH FAM 5’(FAM)-ccgtgtgaacggatttggccgtatc-(IABkFQ) 3’ 
NRG-1β Cy5 5’(Cy5)-tggcaacgatcaccagtaaactcatttgg-(IAbRQSp) 3’ 
TGF-β HEX 5’(HEX)-tcgctttgtacaacagcacccgc-( IABkFQ) 3’ 
β-AR HEX  5’(HEX)-cgtatctttctacgtgcccctggt-( IABkFQ) 3’  
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includes the use of DNase, is sufficient to completely remove any contaminating 
genomic DNA, agarose gels were run of the RT-PCR products generated from three 
independent cellular RNA extracts previously incubated with or without 1.5-2.0 U 
RNase. If the RT-PCR products are derived only from mRNA, and not contaminating 
genomic DNA, this RNase treatment should eliminate all bands. These experiments 
were carried out as detailed in Table 3.3.  
3.2.7 Quantitative reverse transcriptase polymerase chain reaction  
 To measure relative gene expression, QIAGEN OneStep RT-PCR was 
undertaken using a QIAGEN Rotor-Gene Q6000 (QIAGEN, Hilden, Germany). For 
each RNA extract a PCR reaction was set-up in a UV-sterilised, RNase-free PCR tube 
(Axygen - Fisher Biotec, Perth, Western Australia), containing forward and reverse 
primers as well as the TaqMan probes for the reference gene and the genes of interest. 
The total volume for each reaction was 25 μL as shown for GAPDH, NRG-1β and 
TGF-β in Table 3.4 and for GAPDH and β-AR in Table 3.5.  
 In order to optimize the RT-PCR conditions, a test was conducted by 
varying the annealing temperature between 55-59ᵒC and it was established that 57ᵒC 
provided the best specificity and the highest yield of product. Thus the reaction 
mixtures were incubated at 50°C for 30 minutes followed by denaturation at 95ᵒC for 15 
minutes. This was followed by 40 cycles using the following parameters; 94°C for 30 
sec; 57°C for 30 sec and 72°C for 60 sec. The reactions were then held at 72°C for 10 
minutes. The RT-PCR products were then either subjected to agarose gel 
electrophoresis or the expression of the test genes relative to GAPDH was ascertained 
using the method of Pfaffl (2001). 
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Table 3.3 Pre-treatment of cellular RNA extracts with RNase.  
RNA extracts were subjected to the following incubation and 3.8 μL of each of the 
incubations ( RNase), equivalent to 5 ng of RNA, was subjected to multiplex RT-PCR.  
 
 
 -RNase +RNase 
mRNA template (27.78 ng) 10 μL 10 μL 
10x TNE buffer 2 μL 2 μL 
RNase-free water 8 μL 4 μL 
RNase solution (1.5-2.0 U) - 4 μL 
 Incubate at 37ᵒC for 30 minutes 
105 mM  DTT in RNase-free 
water 
1 μL 1 μL 
 Incubate at 70ᵒC for 20 minutes 
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Table 3.4 Components for a OneStep multiplex qPCR reaction for NRG-1β. 
 
Component Volume (μL) Final concentration 
5xQIAGEN OneStep RT-PCR 
buffer 
5.0  
dNTP 1.0 400 μM of each dNTP 
QIAGEN OneStep RT-PCR 
enzyme mix 
1.0  
GAPDH forward/reverse primers 0.5 0.2 μM 
NRG-1β forward/reverse primers 0.5 0.2 μM 
TGF-β forward/reverse primers 0.5 0.2 μM 
GAPDH probe 0.5 50 nM 
NRG-1β probe 0.5 50 nM 
TGF-β probe 0.5 50 nM 
RNA extract from fibroblasts  Aliquot equivalent to 5 ng 
RNA 
200 ng/mL 
RNase-free water Water to final volume = 
25μL 
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Table 3.5 Components for a OneStep multiplex qPCR reaction for β-AR. 
 
Component Volume (μL) Final concentration 
5xQIAGEN OneStep RT-PCR 
buffer 
5.0  
dNTP 1.0 400 μM of each dNTP 
QIAGEN OneStep RT-PCR 
enzyme Mix 
1.0  
GAPDH forward/reverse primers 0.25 0.1 μM 
β-AR forward/reverse primers 1.0 0.4 μM 
GAPDH probe 0.5 50 nM 
β-AR probe 0.5 50 nM 
RNA extract from type II cells Aliquot equivalent to 5 ng 
RNA 
200 ng/mL 
RNase-free water Water to final volume = 
25μL 
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3.2.8 Agarose gel electrophoresis 
 Agarose gels were prepared by dissolving 1.5 g molecular biology grade 
agarose in 100 mL of 40 mM Tris-HCl buffer, pH 8.0, containing 20 mM acetic acid, 
10 mM EDTA and the mixture heated in a microwave until the agarose was completely 
dissolved. After cooling 1.5 μL of SYBR Safe solution (Invitrogen) was added, the gels 
were poured and allowed to set in a 4ᵒC cold room for approximately 30 minutes. An 
aliquot of each RT-PCR incubation mixture (Section 3.2.7) was mixed with loading 
buffer containing bromophenol blue, xylene cyanol FF in 30% glycerol. Aliquots (5 μL) 
of each sample and 5 μL of a 100-3000 bp DNA ladder (Axygen - Fisher Biotec, Perth, 
Western Australia) were loaded onto an agarose gel. Electrophoresis was performed in a 
BioRad slab gel electrophoresis unit (a wide, mini-sub cell GT) using a BioRad power 
Pac 300 set at 90 V until the dye was almost at the end of the gel. A photograph of the 
gel was taken under blue light using a Vilber Lourmat Bio-Vision+1000 camera (Fisher 
Biotec, Perth, Western Australia).    
3.2.9 Statistical analyses   
Results were tabulated and graphed using Microsoft Excel and statistical 
analyses were carried out using SPSS Statistics 21.0 for Windows. Repeated measures 
ANOVA was used to analyze for the differences between 3 or more experimental 
conditions. If significant, the ANOVA was followed by Dunnett pairwise comparisons to 
test for differences from both the control and dexamethasone groups. 
3.3 Results 
3.3.1 Effect of dexamethasone on neuregulin-1β gene expression 
3.3.1.1 Gel of singleplex GAPDH, neuregulin-1β and TGF-β RT-PCR products 
The products from singleplex RT-PCR reactions, carried out using RNA 
extracts from cultured rat lung fibroblasts, grown under control conditions, and primers 
for glyceraldehyde-3-phosphate dehydrogenase (GAPDH), neuregulin-1β (NRG-1β) or 
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transforming growth factor-β (TGF-β) primers, were electrophoresed on an agarose gel, 
as described in 3.2.8. For each of these primers a single band was observed of the size 
expected for the corresponding pair of primers (i.e. GAPDH 207 bp; neuregulin-1β 196 
bp; and TGF-β 392 bp) (Figure 3.5). The GAPDH and NRG-1β PCR products, which 
are of similar size, migrate to a similar position (i.e. adjacent to the 200 bp band of the 
DNA ladder), whereas the TGF-β PCR product expectedly migrates adjacent to the 400 
bp band of the DNA ladder. 
3.3.1.2 Gel of the products derived from both a multiplex and singleplex 
neuregulin-1β RT-PCR  
The products from RT-PCR, carried out using either multiplex PCR with 
primers for GAPDH, neuregulin-1β and TGF-β or a singleplex PCR using only primers 
for neuregulin-1β, were electrophoresed on an agarose gel. As the primers for GAPDH 
and neuregulin-1β yield products of similar size, which are distinct from those 
generated using TGF-β primers, only two bands were observed under multiplex 
conditions. The singleplex product generated using only neuregulin-1β primers yielded 
a single band, which corresponded to the smaller of the two multiplex bands. It is 
possible that, under multiplex conditions, separate GAPDH and NRG-1β PCR products 
are generated but because of their similar size they are not separated on the agarose gel 
(Figure 3.6). Such a conclusion was verified when the multiplex PCR products from 
similar fibroblast RNA extracts were run on an Agilent 2100 Bioanalyser producing 
three separate bands corresponding to 199, 214 and 392 bp, which are very close to the 
expected size of NRG-1β, GAPDH and TGF-β products, respectively (Figure 3.7).   
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Lane            1             2            3            4            5            6           7            8 
 
Figure 3.5 Agarose gel of the singleplex RT-PCR products using GAPDH, 
neuregulin-1β and TGF-β primers. 
RNA from cultured rat lung fibroblasts was extracted and quantified as described in 
3.2.4.2 and 3.2.4.3, respectively. Singleplex RT-PCR was carried out using primers for 
GAPDH, neuregulin-1β and TGF-β. An agarose gel was prepared and the RT-PCR 
products run as described in 3.2.8. The GAPDH and NRG-1β primers yielded single 
bands of approximately 200 bp whereas the TGF-β primers yielded a single band of 
approximately 400 bp. Lanes 1 and 8 - 100-3000 bp DNA ladder; lanes 2 and 3 - 
GAPDH; lanes 4 and 5 - neuregulin-1β; lanes 6 and 7 - TGF-β.        
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                    ________________    _______________ 
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Figure 3.6 Agarose gel of multiplex (GAPDH/neuregulin-1β/TGF-β) and 
singleplex neuregulin-1β RT-PCR products. 
RNA from cultured rat lung fibroblasts was extracted and quantified as described in 
3.2.4.2 and 3.2.4.3, respectively. Both multiplex RT-PCR, using primers for GAPDH, 
neuregulin-1β and TGF-β, and singleplex RT-PCR, using only neuregulin-1β primers, 
were carried out in duplicate. An agarose gel was prepared and the RT-PCR products 
run as described in 3.2.8. Lanes 1 and 6 – 100-3000 bp DNA ladder; lanes 2 and 3 – 
multiplex GAPDH/neuregulin-1β/TGF-β; lanes 4 and 5 - singleplex neuregulin-1β.        
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Figure 3.7 Separation of multiplex GAPDH, neuregulin-1β and TGF-β PCR 
products on an Agilent 2100 Bioanalyzer.   
RNA extracts from cultured rat lung fibroblasts were prepared as described in the 
legend to Figure 3.6. Multiplex RT-PCR was carried out using primers for GAPDH, 
neuregulin-1β, and TGF-β and the products separated using an Agilent 2100 
Bioanalyzer. Lane 1 - 50-7000 bp DNA ladder; lanes 2 and 3 - GAPDH/neuregulin-1β/ 
TGF-β multiplex products from two separate RNA extracts. 
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3.3.1.3 Standard curves for qPCR of fibroblast mRNA extracts   
Multiplex qPCR was carried out using primers and probes for GAPDH 
(FAM), neuregulin-1β (Cy5) and TGF-β (HEX) with cultured rat lung fibroblast RNA 
extracts either undiluted or diluted 10-, 100-, 1000- or 10,000-fold. As the primers for 
GAPDH and neuregulin-1β yield products of similar size, which are distinct from that 
generated using TGF-β primers, only two bands were observed on the gel. Because the 
qPCR was run for 40 cycles, a decrease in the intensity of the bands was only evident at 
the two lowest concentrations of template (Figure 3.8). Screen images using the 
QIAGEN Rotor-Gene Q 6000 software were captured to show the result for each of the 
probes - GAPDH (FAM), neuregulin-1β (Cy5) and TGF-β (HEX).  
The cycle threshold values (Ct) for each of GAPDH (FAM [green] channel), 
neuregulin-1β (Cy5 [red] channel) and TGF-β (HEX [yellow] channel) increased as the 
template concentration decreased. For the template concentration range of 0.022-219.2 
pg.μL-1 the Ct values declined from 31.38-19.45 for GAPDH, from 36.5-23.6 for NRG-
1β and from 37.7-25.3 for TGF-β (Figure 3.9). Standard curves for GAPDH, NRG-1β 
and   TGF-β  were  established  by  plotting  the  corresponding  Ct  values  against the 
template concentration.  Each  curve  revealed a linear  relationship  between  these  two 
parameters (R
2
  0.99; see Figures 3.10, 3.11 and 3.12). The efficiency (E) values were 
estimated to be 113%, 84% and 109% for GAPDG, NRG-1β and TGF-β, respectively.  
3.3.1.4 Effect of dexamethasone on neuregulin-1β and TGF-β gene expression 
in cultured rat lung fibroblasts 
When cultured rat lung fibroblasts were exposed to dexamethasone 
(20 or 50 nM) or an equivalent volume of propylene glycol (vehicle), the steroid was 
shown  to  have no effect  on  the expression of either the neuregulin-1 or TGF-β gene, 
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Figure 3.8 Gel of the multiplex (GAPDH/NRG-1β/TGF-β) PCR products 
generated with different concentrations of the fibroblast mRNA 
extract.   
RNA from cultured rat lung fibroblasts was extracted and quantified as described in 
3.2.4.2 and 3.2.4.3, respectively. Multiplex RT-PCR was carried out in triplicate using 
GAPDH, neuregulin-1β and TGF-β primers at five different template concentrations. 
An agarose gel was prepared and the RT-PCR products run as described in 3.2.8. Lanes 
1 and 18 - 100-3000 bp DNA ladder; lanes 2, 3 and 4 – undiluted template; lanes 5, 6 
and 7 - 1/10 diluted template; lanes 8, 9 and 10 - 1/100 diluted template; lanes 11, 12 
and 13 - 1/1000 diluted template; lanes 14, 15 and 16 - 1/10000 diluted template; 
lane 17 - water. 
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Figure 3.9 Amplification profiles of the GAPDH, NRG-1β and TGF-β 
standard curves. 
The fibroblast mRNA extraction and analytical procedures are as described in Figure 
3.8. Screen images of the cDNA amplification profiles at five different template 
concentrations were captured using the (A) FAM (green), (B) Cy5 (red) and (C) HEX 
(yellow) channels to detect binding of the specific probes for GAPDH, NRG-1β and 
TGF-β, respectively. 
B 
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Figure 3.10 Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) standard 
curve from the multiplex qPCR products of fibroblast mRNA 
extracts.  
The fibroblast mRNA extraction and analytical procedures are as described in Figure 
3.8. The extract was subjected to multiplex qPCR at various dilutions and then analyzed 
using a FAM-labeled GAPDH probe to ascertain the Ct values at each concentration of 
the extract. Each data point represents the mean  SEM of triplicate determinations.    
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Figure 3.11 Neuregulin-1β standard curve from multiplex qPCR products of 
fibroblast mRNA extracts. 
The fibroblast mRNA extraction and analytical procedures are as described in Figure 
3.8. The extract was subjected to the multiplex qPCR at various dilutions and then 
analysed using a Cy5-labeled neuregulin-1β probe to ascertain the Ct values at each 
concentration of the extract. Each data point represents the mean  SEM of triplicate 
determinations.   
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Figure 3.12 TGF-β standard curve from multiplex qPCR products of 
fibroblast mRNA extracts. 
The fibroblast mRNA extraction and analytical procedures are as described in Figure 
3.8. The extract was subjected to multiplex qPCR at various dilutions and then analysed 
using a HEX-labeled TGF-β probe to ascertain the Ct values at each concentration of 
the extract. Each data point represents the mean  SEM of triplicate determinations.    
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irrespective of the duration of exposure. This conclusion is based on the observation 
that the relative amounts of neuregulin-1β and TGF-β mRNA, as determined by 
multiplex qPCR and quantified using the Pfaffl method (Pfaffl, 2001) were not 
significantly affected (p > 0.05; Tables 3.6 and 3.7). The large values for SEM in these 
two tables is almost certainly due to the fact that for both neuregulin-1β and TGF-1β  
the expression of is very much lower than that of GAPDH thus meaning that they are 
close to the limit of detection.   
3.3.2 Effect of neuregulin-1β on β-adrenergic receptor gene expression 
3.3.2.1 RT-PCR of β-adrenergic receptor mRNA in type II cell extracts in the 
presence and absence of RNase  
The β-adrenergic receptor gene contains no introns and therefore no splice junctions in 
the corresponding mRNA (Emorine et al., 1987; Kobilka et al., 1987; Chatterjee et al., 
1997). Because of this, any products formed during RT-PCR of type II cell extracts 
could be generated from either mRNA or contaminating genomic DNA. In order to test 
whether there was DNA contamination of the type II cell extracts, RT-PCR was carried 
out using extracts previously incubated with and without RNase. When the RT-PCR 
products from type II cell extracts not treated with RNase were analyzed on an agarose 
gel (Figure 3.13), single PCR products of the appropriate size were observed for 
GAPDH (207 bp), Pgk (253 bp), Rpl13a (242 bp) and β-AR (152 bp), if the template 
was not previously treated with RNase. The transferrin receptor (Tfrc) gene appears not 
to be  expressed  in  type II  cells   (Figure 3.13).   If  the  template  was   incubated with  
1.5-2 U RNase prior to RT-PCR no bands were observed using any of the primers. This 
demonstrates that the products observed in the absence of RNase were not the result of 
genomic DNA contamination of the template. Similar results were obtained with two 
separate RNA extracts.  
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Table 3.6  Expression of the neuregulin-1 gene in lung fibroblasts after 
exposure to dexamethasone. 
Cultured fetal rat lung fibroblasts were exposed to MEM
+
 containing 20 or 50 nM 
dexamethasone or an equivalent volume of propylene glycol (vehicle). After the 
indicated exposure time, the cells were subjected to RNA extraction and the mRNA 
concentration of these extracts quantified as described in 3.2.4.2 and 3.2.4.3, 
respectively. The level of neuregulin-1 mRNA was determined using multiplex qPCR, 
as described in 3.2.7. The data represent the mean  SEM of the indicated number of 
independent fibroblast cultures.  
 
 
 
 
 
 
Exposure time 
Neuregulin-1 gene expression in lung fibroblasts 
after exposure to dexamethasone 
(relative to a control value of 1.00) 
20 nM dexamethasone 50 nM dexamethasone 
4 hours 0.93 ± 0.33 (5) 0.95 ± 0.41 (5) 
6 hours 0.76 ± 0.12 (3) 0.58 ± 0.17 (3) 
8 hours 0.89 ± 0.15 (6) 1.01 ± 0.35 (7) 
24 hours 0.73 ± 0.42 (3) 1.10 ± 0.80 (3) 
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Table 3.7 Expression of the TGF- gene in lung fibroblasts after their 
exposure to dexamethasone. 
Cultured fetal rat lung fibroblasts were exposed to MEM
+
 containing 20 or 50 nM 
dexamethasone or an equivalent volume of propylene glycol (vehicle). After the 
indicated exposure time, the cells were subjected to RNA extraction and the mRNA 
concentration of these extracts quantified as described in 3.2.4.2 and 3.2.4.3, 
respectively. The level of TGF- mRNA was determined using multiplex qPCR, as 
described in 3.2.7. The data represent the mean  SEM of the indicated number of 
independent fibroblast cultures.  
 
 
 
 
 
 
 
 
Exposure time 
TGF- gene expression in lung fibroblasts after 
exposure to dexamethasone 
(relative to a control value of 1.00) 
20 nM dexamethasone 50 nM dexamethasone 
4 hours 0.99 ± 0.20 (5) 0.59 ± 0.15 (5) 
6 hours 1.51 ± 0.47 (3) 1.00 ± 0.40 (3) 
8 hours 0.47 ± 0.11 (5) 0.76 ± 0.32 (5) 
24 hours 0.45 ± 0.24 (3) 0.47 ± 0.30 (3) 
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Figure 3.13 RT-PCR of the β-adrenergic receptor mRNA in type II cell 
extracts  RNase.  
RT-PCR was carried out using singleplex primers for GAPDH, Pgk, Rpl13a, Tfrc and 
β-adrenergic receptor (β-AR) and type II cell extracts before and after treatment with 
1.5-2U RNase. An agarose gel was prepared and the RT-PCR products run as described 
in 3.2.8. Lanes 1 and 12 - 100-3000 bp DNA ladder; lanes 2, 3, 4, 5 and 6 - GAPDH, 
Pgk, Rpl13a, Tfrc and β-AR (no RNase treatment of template), respectively; lanes 7, 8, 
9, 10 and 11 - GAPDH, Pgk, Rpl13a, Tfrc and β-AR (after RNase treatment of 
template), respectively.    
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3.3.2.2  Interaction between the RT-PCR primers for the β-adrenergic receptor 
and various reference genes 
To determine which reference gene(s) would be most suitable in a multiplex 
PCR, an agarose gel was run of the RT-PCR products from RNA extracts of cultured rat 
lung type II cells using primers for GAPDH, Pgk, Rpl13a and β-AR, in singleplex and 
multiplex reactions. A single band was observed for each of the primer pairs, with the 
exception of those for Pgk, which had an additional faint band (Figure 3.14). For all 
multiplex incubations, except those of β-AR/GAPDH and β-AR/Pgk (lanes 8 and 9 of 
Figure 3.14), unexpected bands were apparent, indicating non-specific amplifications. 
Given that other researchers (Mak et al., 1995a; Togaria et al., 1997; Shi et al., 2011) 
have used GAPDH as a reference gene with type II cells, all further studies were carried 
out using only GAPDH and β-AR in multiplex reactions. As three other potential 
reference genes, namely ACTB, Ppia and Tfrc, were shown not to be expressed at a 
sufficiently high level in type II cells, these were also deemed to be not suitable as 
reference genes.  
3.3.2.3 Comparison of singleplex and multiplex RT-PCR products for both 
GAPDH and β-adrenergic receptor mRNA   
When singleplex PCR reactions were carried out with either GAPDH or β-AR primers 
the RT-PCR products, when electrophoresed on an agarose gel, yielded single bands of 
the expected size (207 bp and 152 bp, respectively). When these same primers were 
used in a multiplex PCR reaction the same two bands were generated, however, the 
intensity of the smaller β-AR band was reduced (Figure 3.15). Importantly, no 
additional bands were generated when GAPDH or β-AR primers were used in this 
multiplex configuration, indicating that there weren’t any non-specific amplifications.           
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Figure 3.14 Test for any interaction between the RT-PCR primers for the 
β-adrenergic receptor and various reference genes. 
RNA from cultured rat lung type II pneumocytes was extracted and quantified as 
described in 3.2.4.2 and 3.2.4.3, respectively. RT-PCR was carried out using singleplex 
and multiplex primers for GAPDH, Pgk, Rpl13a and β-AR. An agarose gel was 
prepared and the RT-PCR products ran as described in 3.2.8. Lanes 1 and 13 - 100-3000 
bp DNA ladder; lane 2 – singleplex GAPDH; lane 3 – singleplex Pgk; lane 4 –
 singleplex Rpl13a; lane 5 – singleplex β-AR; lane 6 - multiplex β-AR, Pgk and 
GAPDH; lane 7 - multiplex β-AR, Rpl13a and GAPDH; lane 8 - multiplex β-AR and 
GAPDH; lane 9 - multiplex β-AR and Pgk; lane 10 - multiplex β-AR and Rpl13a; 
lane 11 - multiplex β-AR, Rpl13a and Pgk; lane 12 – negative control (water).    
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                      Lane                1            2              3             4      
 
Figure 3.15  Gel of the singleplex and multiplex RT-PCR products for 
GAPDH and β-adrenergic receptor mRNA. 
The type II cell mRNA extraction and analytical procedures are as described in Table 
3.5. Singleplex and multiplex RT-PCR incubations were carried out using 1 μL of 
primers for both GAPDH and β-AR. An agarose gel was prepared and the RT-PCR 
products run as described in 3.2.8. Lane 1 - 100-3000 bp DNA ladder; lane 2 - GAPDH; 
lane 3 - β-AR; lane 4 - multiplex incubation with both GAPDH and β-AR primers. 
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In an attempt to minimize the reduction in the β-AR band, different relative 
concentrations of the GAPDH and β-AR primers were used. When the GAPDH primers 
were reduced to 0.05 μM and the β-AR primers increased to 0.4 μM (i.e. an 8-fold 
increase in the relative concentration of the latter) there was a decrease in the intensity 
of the GAPDH band and an increase in that of the β-AR band (Figure 3.16 – lane 3). 
When 0.1 μM of GAPDH and 0.4 μM β-AR primers were used (i.e. a 4-fold increase in 
the relative concentration of the latter), both GAPDH and β-AR bands were of high 
intensity. This latter relative ratio of the two primers was used in all subsequent 
experiments.    
3.3.2.4 Standard curves for qPCR of type II cell mRNA extracts   
Multiplex RT-PCR was carried out using primers and probes for GAPDH 
(FAM) and β-AR (HEX) with cultured rat lung type II cells RNA extracts either 
undiluted or diluted 10-, 100-, 1000- or 10,000-fold. Two bands were observed for 
GAPDH (207 bp) and β-AR (152 bp) after being run on an agarose gel. Because the 
RT-PCR was run for 40 cycles, a decrease in the intensity of the bands was only evident 
from about the 100-fold dilution (i.e. lane 8) of the template (Figure 3.17).  Screen 
images using the QIAGEN Rotor-Gene Q 6000 software were captured to show the 
result for each of the probes - GAPDH (56-fam) and β-AR (5hex). The cycle threshold 
values (Ct) for each of GAPDH (FAM [green] channel) and β-AR (HEX [yellow] 
channel) increased as the template concentration decreased. For the template 
concentration range of 0.202-202.4 pg.μL-1 the Ct values declined from 31.0-21.5 for 
GAPDH and from 36.5-26.4 for β-AR (Figure 3.18). Standard curves for GAPDH and 
β-AR were established by plotting the corresponding Ct values against the template 
concentration. Each  curve  revealed a linear relationship  between these two parameters 
 
Chapter 3 NRG-1β and β-AR gene expression 
119 
 
    
 
                                Lane          1        2       3        4        5 
 
Figure 3.16 Effect of varying the concentrations of GAPDH and β-adrenergic 
receptor primers on the multiplex RT-PCR products. 
The type II cell mRNA extraction and analytical procedures are as described in 
Table 3.5. RT-PCR was carried out using multiplex primers for GAPDH and β-AR at 
different concentrations of the primers. An agarose gel was prepared and the RT-PCR 
products run as described in 3.2.8. Lanes 1 and 5 - 100-3000 bp DNA ladder; lane 2 – 
multiplex using 0.2 μM of both GAPDH and β-AR primers; lane 3 – multiplex using 
0.05 μM of GAPDH and 0.4 μM of β-AR primers; lane 4 - multiplex using 0.1 μM of 
GAPDH and 0.4 μM of β-AR primers. 
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Figure 3.17 Gel of the multiplex (GAPDH/β-AR) PCR products of different 
concentrations of type II pneumocyte mRNA extracts.   
RNA from cultured rat lung type II pneumocytes was extracted and quantified as 
described in 3.2.4.2 and 3.2.4.3, respectively. Multiplex RT-PCR was carried out in 
triplicate using GAPDH and β-AR primers at five different template concentrations. An 
agarose gel was prepared and the RT-PCR products run as described in 3.2.8. Lanes 1 
and 17 – 100-3000 bp DNA ladder; lanes 2, 3 and 4 – undiluted template; lanes 5, 6 
and 7 - 1/10 diluted template; lanes 8, 9 and 10 - 1/100 diluted template; lanes 11, 12 
and 13 - 1/1000 diluted template; lanes 14, 15 and 16 - 1/10000 diluted template.  
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Figure 3.18  Amplification profiles of the GAPDH and β-AR standard curves. 
The type II pneumocyte mRNA extraction and analytical procedures are as 
described in Figure 3.8. Screen images of the cDNA amplification profiles at five 
different template concentrations were captured using the (A) FAM (green), (B) HEX 
(yellow) channels to detect binding of the specific probes for GAPDH and β-AR, 
respectively. 
 
 
 
 
 
 
B 
A 
Chapter 3 NRG-1β and β-AR gene expression 
112 
 
 (R
2
  0.997; see Figures 3.19 and 3.20). The efficiency (E) values were estimated to be 
108% and 97% for GAPDH and β-AR, respectively.   
3.3.2.5 Effects of neuregulin-1β and dexamethasone on β-adrenergic receptor 
gene expression in type II pneumocytes 
Multiplex qPCR was carried out using both GAPDH and β-AR primers, 
together with the specific fluorescently-labeled TaqMan probes, for each of the qPCR 
products. RNA extracts were prepared from cultured type II pneumocytes that had been 
previously exposed to 20, 50 and 100 ng.mL
-1
 heregulin-1β for 2 or 4 hours. These 
extracts were then subjected to multiplex qPCR and the level of β-AR gene expression 
was determined using the Pfaffl method (Pfaffl, 2001). There was no significant effect 
of the heregulin-1β on the level of β-AR gene expression when compared to that in the 
control extracts (Table 3.8).  
 A more extensive study was conducted in which the effects of 
dexamethasone (a known inducer of the β-adrenergic receptor) (Hadcock and Malbon, 
1988; Cornett et al., 1998) and heregulin-1β, alone and in combination, were 
determined.   An approximate 2-fold increase in the expression of the β-AR gene             
(p < 0.05) was observed when type II cells were exposed to 50 nM dexamethasone for 
6 hours (Figure 3.21). When the cells were exposed only to the indicated concentrations 
of heregulin-1β for the same duration, there was no significant effect on the level of 
β-AR mRNA. Moreover, when the cells were exposed to dexamethasone and 
heregulin-1β for 6 hours the level of β-AR mRNA was significantly different from that 
found in control cells (p < 0.01) but not significantly  different  (p > 0.05)  from  that  in  
dexamethasone-treated cells. 
 When type II cells were likewise exposed to 50 nM dexamethasone for an 
extended  period  of 8 hours  there was a 2-fold increase in the level of expression of the 
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Figure 3.19 GAPDH standard curve from the multiplex qPCR products of the 
mRNA extracts from type II cells.  
Type II cell mRNA extraction and analytical procedures are as described in Figure 3.18. 
The extract was subjected to multiplex qPCR at various dilutions and then analyzed 
using a FAM-labeled GAPDH probe to ascertain the Ct values at each concentration of 
the extract. Each data point represents the mean  SEM of triplicate determinations.    
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Figure 3.20 β-adrenergic receptor standard curve from the multiplex qPCR 
products of the mRNA extracts from type II cells.  
Type II cell mRNA extraction and analytical procedures are as described in Figure 3.18. 
The extract was subjected to multiplex qPCR at various dilutions and then analyzed 
using a HEX-labeled β-adrenergic receptor probe to ascertain the Ct values at each 
concentration of the extract. Each data point represents the mean  SEM of triplicate 
determinations.    
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Table 3.8 Expression of the -adrenergic receptor gene in lung type II cells 
after exposure to heregulin-1β. 
Rat type II cells were isolated from fetal lung tissue and grown in culture for 3 days 
prior to exposing them to MEM
+
 containing 20, 50 or 100 ng.mL
-1
 of heregulin-1β or an 
equivalent volume of water (control). After the indicated exposure times, the cells were 
subjected to RNA extraction and the mRNA concentration of these extracts quantified 
as described in 3.2.4.2 and 3.2.4.3, respectively. The level of -AR mRNA was 
determined using qPCR, as described in 3.2.7. The data represent the mean  SEM of 
the specified number of independent type II cells cultures.  
 
 
 
 
 
Exposure 
time 
-adrenergic receptor gene expression in lung type II cells  
after exposure to heregulin-1β 
(relative to a control value of 1.00) 
20 ng.mL
-1
             50 ng.mL
-1
 100 ng.mL
-1
 
2 hours 1.28 ± 0.03 (4) 0.80 ± 0.16 (6) 0.97 ± 0.43 (4) 
4 hours 1.06 ± 0.13 (4) 0.99 ± 0.08 (6) 0.94 ± 0.24 (4) 
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Figure 3.21 Effect of neuregulin-1β on β-adrenergic receptor gene expression 
in type II pneumocyte after 6 h exposure. 
Rat type II cells were isolated from fetal lung tissue and grown in culture for 3 days 
prior to exposing them to MEM
+
 containing 20, 50 or 100 ng.mL
-1
 of heregulin-1β or an  
equivalent volume of water (control) with or without 50 nM dexamethasone. After 6 h 
of further incubation, the cells were subjected to RNA extraction and the mRNA 
concentration of these extracts quantified as described in 3.2.4.2 and 3.2.4.3, 
respectively. The level of -AR mRNA was determined using multiplex qPCR with 
both GAPDH and β-AR primers, as described in 3.2.7. The results, which represent the 
level of β-AR gene expression relative to that in control cells, are the mean ± SEM of 5 
separate experiments conducted in duplicate. Significant differences from the level of 
expression in control cells are indicated with asterisks ( p < 0.05,  p < 0.01).  
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β-AR gene. However, although there was no significant effect of neuregulin-1β alone, 
the β-AR mRNA level was significantly greater when the cells were exposed to either 
50 or 100 ng.mL
-1
 heregulin-1β, in combination with dexamethasone, when compared 
to steroid treatment alone (p < 0.05 and p < 0.001, respectively). This indicates that 
dexamethasone and heregulin-1β act synergistically if the exposure time is at least 8 
hours (Figure 3.22). 
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Figure 3.22 Effect of neuregulin-1β on β-adrenergic receptor gene expression 
in type II pneumocyte after 8 h exposure. 
Rat type II cells were isolated from fetal lung tissue and grown in culture for 3 days 
prior to exposing them to MEM
+
 containing 20, 50 or 100 ng.mL
-1
 of heregulin-1β or an  
equivalent volume of water (control) with or without 50 nM dexamethasone. After 8 h 
of further incubation, the cells were subjected to RNA extraction and the mRNA 
concentration of these extracts quantified as described in 3.2.4.2 and 3.2.4.3, 
respectively. The level of -AR mRNA was determined using multiplex qPCR with 
both GAPDH and β-AR primers, as described in 3.2.7. The results, which represent the 
level of β-AR gene expression relative to that in control cells, are the mean ± SEM of 5 
separate experiments conducted in duplicate. Significant differences from the level of 
expression in those cells exposed only to dexamethasone are indicated by asterisks 
( p < 0.05;   p < 0.001). 
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3.4 Discussion  
3.4.1 Effect of dexamethasone on neuregulin-1β gene expression  
 Before ascertaining the effect of glucocorticoids on neuregulin-1β gene 
expression in lung fibroblasts several tests were conducted to confirm that, during 
RT-PCR, there was no interaction between the primers or probes for GAPDH (reference 
gene), neuregulin-1β (target gene) and TGF-β, a gene reported to be attenuated by 
glucocorticoid treatment (McDevitt et al., 2007). In addition, standard curves were 
established for each of these gene products. 
 Primers, together with mRNA extracts from lung fibroblasts from day 19 
fetal rats, were run as separate and multiplex RT-PCR incubations. Upon completion of 
the RT-PCR, samples were subjected to electrophoresis on agarose gels, which 
confirmed that the products observed were the anticipated size for each of the primer 
pairs used (i.e. GAPDH 207 bp; neuregulin-1β 196 bp and TGF-β 392 bp) and indicated 
that, under singleplex RT-PCR incubation conditions, the products contained only those 
that were expected. Under multiplex conditions only the expected bands were generated 
which demonstrates that there was no interference between the various primers and 
probes.  
 When the mRNA template was increasingly diluted and RT-PCR carried out 
followed by a separation of the products on an agarose gel, a decrease in the intensity of 
the bands was only evident at the two highest levels of dilution. Screen capture images 
of the GAPDH (56-fam), neuregulin-1β (5cy5) and TGF-β (5hex) products on the 
appropriate channels showed an increase in the cycle threshold values (Ct) as the 
template concentration decreased. Standard curves were established by plotting these Ct 
values against the template concentration thus providing an efficiency value (E) for each 
gene product. The efficiency values for GAPDH, neuregulin-1β and TGF-β were 113%, 
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84% and 109%, respectively. The Ct values for both test (20 and 50 nM 
dexamethasone) and control conditions, together with the efficiency values, were used 
in the determination of neuregulin-1β and TGF-β gene expression using the method of 
Pfaffl (2001), which calculates the relative expression of the target genes in comparison 
to that of the housekeeping gene GAPDH. Irrespective of the concentration of 
dexamethasone used, or the time of exposure to the steroid, there was neither a 
significant enhancement nor suppression in the expression of the neuregulin-1β or 
TGF-β genes, respectively. This shows that the higher level of neuregulin-1β produced 
by lung fibroblasts in the presence of dexamethasone (Maker, 2008) was not the result 
of enhanced neuregulin-1β gene expression. Given that neuregulins are produced as 
transmembrane precursors, which are considered to generate diffusible ligands when 
subjected to cleavage (Crovello et al., 1998), it is possible that dexamethasone 
stimulates the rate of cleavage of the neuregulin precursors. Such a cleavage of 
membrane-bound pro-NRG protein leading to the release of soluble neuregulin-1β has 
been show to occur in neuronal cells when activation of protein kinase C by 
neurotrophin results in the phosphorylation of the membrane-bound, precursor protein 
(Esper and Loeb, 2009). Other possibilities are raised in the General Discussion.      
 The failure of dexamethasone to significantly reduce the expression of 
TGF-β in rat lung fibroblasts (see Table 3.7) is in contrast to the observation of 
McDevitt et al. (2007), who showed that the level of TGF-β in fetal human lung 
epithelial cells was diminished when the cells were exposed to dexamethasone. Given 
that both rat lung fibroblasts and type II cells contain an almost identical concentration 
of the glucocorticoid receptor (Damas, 2010), the contradiction referred to above is thus 
likely to be due to the TGF-β gene of fetal human lung epithelial cells and rat lung 
fibroblasts  being differently affected by glucocorticoids.    
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3.4.2 Effect of neuregulin-1β on β-AR gene expression 
 Because β-AR gene has no introns (Emorine et al., 1987; Kobilka et al., 1987; 
Chatterjee et al., 1997), an experiment was carried out with and without RNase 
treatment of the template. It was established that pre-treatment of the template with 
RNase eliminated the formation of any RT-PCR product using primers not only for 
β-AR but also for Pgk, Rpl13a and GAPDH. This confirms that the DNase, present 
during the RNA extraction, was sufficient to remove any contaminating genomic DNA 
and that any product formed was derived from extracted cellular RNA.  
 Additional experiments showed that the transferin receptor (Tfrc) gene was 
not expressed in type II cells and that there was an undesirable interaction between the 
primers for β-AR and Rpl13a in a multiplex incubation (Figure 3.14). This renders both 
Tfrc and Rpl13a unsuitable candidates to act as the reference gene. In contrast, both 
GAPDH and Pgk met all the requirements for this role including no sign of any 
interactions between the primers for these reference genes and those of the β-AR gene 
in a multiplex incubation. Given that other researchers (Mak et al., 1995a; Togari et al., 
1997; Togaria et al., 1997; Shi et al., 2011) have used GAPDH as the reference gene for 
type II cells, all of the studies reported here were carried out using only GAPDH and 
β-AR primers in multiplex reactions. Initial experiments gave a diminished signal for 
the β-AR product when both GAPDH and β-AR primers were present in a multiplex 
reaction. This problem was solved by changing the relative concentrations of the two 
sets of primers. When GAPDH primers were reduced to 0.1 μM and the concentration 
of the β-AR primers increased to 0.4 μM both GAPDH and β-AR bands were of high 
intensity. This latter relative ratio of the two primers was used in all further 
experiments.  
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 When the mRNA template was serially diluted as described in Figure 3.17, 
subjected to RT-PCR and the products analysed using agarose gels, the intensity of the 
bands showed a progressive decrease from a 100-fold dilution of the template. The 
results presented in the screen capture images of the GAPDH and β-AR qPCR products 
in the 56-fam (green) and 5hex (yellow) channels, respectively, showed increasing cycle 
threshold values (Ct) as the template concentration decreased. Standard curves were 
established by plotting the Ct values against the template concentration to provide the 
efficiency values (E) for each gene product. The efficiency values for GAPDH and 
β-AR were 108% and 97%.  
 The Ct values for each of the test (20, 50 and 100 ng.mL
-1
 heregulin-1β) and 
control conditions, together with the efficiency values, were used in conjunction with 
the method of Pfaffl (2001) to determine the impact of heregulin-1β on the extent of 
β-AR gene expression in type II pneumocytes. Irrespective of whether the cells were 
exposed to heregulin-1β for 2, 4, 6 or 8 hours there was no increase in the expression of 
the β-AR gene (Table 3.8; Figures 3.21 and 3.22). In contrast, if the type II cells were 
incubated with 50 nM dexamethasone for 6 hours, there was a significant increase (p < 
0.05) in the level of expression of the β-AR gene as compared to control cultures. This 
is in agreement with numerous investigators who have shown similar levels of induction 
of the β-AR gene after glucocorticoid administration in a variety of tissues (Collins et 
al., 1988; Hadcock and Malbon, 1988; Hadcock et al., 1989; Mak et al., 1995a; Dangel 
et al., 1996; Cornett et al., 1998), including the lung (Mak et al., 1995a; Cornett et al., 
1998). Although the expression of the β-AR gene was also elevated when type II cells 
were exposed to 20, 50 and 100 ng.mL
-1
 heregulin-1β in the presence of 50 nM 
dexamethasone (p < 0.01), this was not significantly different from that which occurred 
with exposure to dexamethasone alone.  
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 However, when the type II cells were exposed to these same agents for an 
extended period of 8 hours, although a similar level of induction of the β-AR gene 
occurred when the cells were exposed only to dexamethasone, and there was no effect 
of heregulin-1β alone, there was a much greater level of induction if the cells were 
exposed to this peptide in the presence of 50 nM dexamethasone (Figure 3.22). This 
enhanced level of induction was only significant when the heregulin-1β concentration 
was 50 or 100 ng.mL
-1
 (3.4-fold; p < 0.05 and 4.2-fold; p < 0.01, respectively, as 
compared to the expression level in cells exposed to dexamethasone alone, i.e. 2.1-fold). 
This is the first time that dexamethasone and heregulin-1β have been shown to act 
synergistically in inducing the expression of the β-AR gene. Damas (2010) has shown 
that, although dexamethasone when applied directly to type II cells increases the β-AR 
activity, the response to this steroid was significantly greater if the type II cells were 
exposed to FCM generated in the presence of dexamethasone (see Figure 3.23). This 
could be explained if the preconditioning of the media by fibroblasts in the presence of 
dexamethasone leads not only to the carryover of the steroid, but also the generation of 
neuregulin-1β leading to a synergistic response. 
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Figure 3.23 Effect of dexamethasone on β-adrenergic receptor activity in 
cultured fetal rat type II cells.  
Rat type II pneumocytes were isolated from fetal lung tissue and grown in 24–well 
tissue culture plates for 3 days as described in 2.2.4. After being washed thoroughly 
using BSS, cells were then incubated for an additional 24 h in either MEM
+
 or 
fibroblast-conditioned media with (  ) and without 100 nM dexamethasone (  ), 
respectively. The cells were then tested for specific β-AR activity as described in 2.2.8. 
The results represent the mean ± SEM of three separate experiments conducted in 
duplicate. This figure is included with the approval of the author, Jolanta Damas 
(Damas, 2010). 
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4.1 Effect of heregulin-1β on surfactant phospholipid synthesis in type II 
cells 
 Although glucocorticoids are known to stimulate the maturation of the lung 
through enhanced surfactant phospholipid synthesis, they have no direct effect on type 
II cells (Smith, 1978; Maker, 2008). However, when lung fibroblasts are cultured in the 
presence of dexamethasone, the resultant fibroblast-conditioned media (FCM) has been 
shown to have a stimulatory effect on surfactant production in cultured type II cells 
(Smith, 1978). This indirect effect of glucocorticoids upon surfactant phospholipid 
synthesis was attributed to a fibroblast-derived peptide, termed fibroblast-pneumocyte 
factor (FPF) (Smith, 1979). It was subsequently reported that purified FPF was able to 
directly stimulate the synthesis of surfactant-associated phospholipids (Post and Smith, 
1984), which resulted from a significant elevation in the activity of choline phosphate 
cytidylyltransferase (Post et al., 1986). Moreover, a monoclonal antibody raised against 
FPF blocked glucocorticoid-induced maturation of the lung (Post et al., 1984). Despite 
numerous attempts to identify FPF (Torday and Kourembanas, 1990; Torday et al., 
2002; Dammann et al., 2003; Maker, 2008), its chemical nature is still not certain. 
Subsequent to the finding of Dammann et al. (2003) that the stimulatory effect of FCM 
could be mimicked by neuregulin-1β and blocked by a neuregulin-1β antibody, Maker 
(2008) showed that FCM generated in the presence of dexamethasone had an elevated 
concentration of neuregulin-1β. Together these findings suggest that neuregulin-1β 
might be, at least, a major component of FPF.    
 The current study has shown that surfactant phospholipid synthesis was 
elevated when type II cells were exposed to the recombinant form of neuregulin-1, 
heregulin-1β (Figures 2.4 and 2.5). This effect was maximal at a heregulin-1β 
concentration of 20 ng.mL
-1
 but was not evident at 100 and 200 ng.mL
-1
. It is suggested 
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that these higher concentrations of the peptide lead to a downregulation of the ErbB 
receptors to which heregulin-1β binds. Such a conclusion is compatible with the 
observations of Cao et al. (2007) that, in MCF-7 breast cancer cells, neuregulin-1 
stimulates both ubiquitination and degradation of the ErbB3 receptor leading to lower 
levels of the receptor when the cells are exposed to high levels of the ligand.  
 The stimulation of surfactant phospholipid synthesis by heregulin-1β in 
cultured fetal type II cells is in agreement with the findings of Dammann et al. (2003)  
that implicate neuregulin-1β as a mediator of the indirect effect of glucocorticoids on 
these cells. It is also compatible with the observation of Maker (2008) that exposure of 
rat lung fibroblasts to dexamethasone led to an elevation in the media concentration of 
neuregulin-1β. However, there was no change in the relative expression of the 
neuregulin-1β gene in response to dexamethasone (Table 3.6), irrespective of the 
concentration or the time of exposure to this steroid. This shows that the higher 
concentration of neuregulin-1β in the media of lung fibroblasts exposed to 
dexamethasone (Maker, 2008) is not the result of enhanced neuregulin-1β gene 
expression. Given that neuregulins are formed as transmembrane precursors, which give 
rise to diffusible ligands when subjected to cleavage (Crovello et al., 1998), it is 
possible that dexamethasone stimulates the rate of cleavage of the neuregulin 
precursors. In this context it is relevant that the growth factor neurotrophin stimulates 
the activation of the δ-isoform of protein kinase C in neuronal cells thereby causing 
phosphorylation and cleavage of the membrane-bound pro-NRG1 protein, thus 
releasing soluble neuregulin-1β (Esper and Loeb, 2009). Alternatively, the effect of 
dexamethasone could be the result of enhanced mRNA or protein stability or the result 
of an elevated rate of mRNA translation.  
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 McDevitt et al. (2007) have previously shown that dexamethasone treatment 
reduces the expression of the TGF-β gene in cultured fetal human type II cells. It was 
reasoned that, if such a decline in TGF-β gene expression also occurred in fetal rat lung 
fibroblasts, this would be a useful indicator of a dexamethasone response in these cells. 
Although there did appear to be a decrease in the level of expression of the TGF-β gene 
in cultured fibroblasts exposed to dexamethasone, particularly after longer exposure 
times, these differences were not statistically significant (Table 3.7). The influence of 
glucocorticoids on lung maturation could be partly accounted for by a decrease in the 
concentration of TGF-β, which has been previously shown to inhibit early 
morphogenesis and block hormone-induced type II cell differentiation (Torday and 
Kourembanas, 1990; McDevitt et al., 2007). Thus the effects of glucocorticoids in 
regulating surfactant production are likely to involve both elevated levels of stimulatory 
factors and diminished levels of inhibitory factors.              
Leptin, which has a molecular weight within the range previously reported 
for FPF (Smith, 1979), has been shown to stimulate surfactant phospholipid synthesis 
by fetal type II pneumocytes in a concentration-dependant manner (Torday and Rehan, 
2002; Torday et al., 2002). Such a finding has been confirmed in the current study 
(Figure 2.6), which showed that leptin was more potent than heregulin-1β (after 4 h 
exposure) in stimulating phospholipid synthesis. The expression of the leptin gene in 
lung fibroblasts has been shown to progressively increase during the latter stages of 
gestation and to be enhanced if these cells are exposed to dexamethasone or parathyroid 
hormone-related protein (PTHrP) (Torday et al., 2002). These authors concluded that, 
based on their similarities, leptin and FPF share a common identity. Subsequently, 
Torday and Rehan (2002) reported that the stretch-induced stimulation of surfactant 
synthesis, a response that is only evident when type II pneumocytes and lung fibroblasts 
are co-cultured, is mediated by PTHrP, leptin and their corresponding receptors. 
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However, in a recent publication, Huang et al. (2012) demonstrated that deletion of 
ErbB1 or downregulation of ErbB4 prevented stretch-induced type II cell 
differentiation. This finding, together with the fact that leptin interacts with the leptin 
(Ob-Rb) receptor and not the ErbB receptors, suggests that factors other than leptin 
might be involved in this response. Moreover, stretch-induced stimulation of lung 
differentiation has been shown to be associated with an elevation in the concentration of 
prostanoids (Copland et al., 2006) and various cytokines (Copland and Post, 2007).   
Although leptin has been proposed as a likely candidate for the role of FPF 
in lung development (Torday et al., 2002), the more recent findings of Dammann el al. 
(2003) together with the observations presented in this thesis suggest that FPF may 
actually be a complex mixture including leptin, neuregulin-1β and other regulatory 
peptides (Copland et al., 2006; Copland and Post, 2007). These various agents could 
account for the range of effects which lead to the development and maturation of the 
lung.  
4.2 Surfactant phospholipid secretion from type II cells.   
 Exposure of type II cells to heregulin-1β resulted in a concentration- and 
time-dependent stimulation of surfactant phospholipid secretion from these cells. After 
a three-hour treatment of the cells with 50 ng.mL
-1
 heregulin-1β, there was a 2.4-fold 
increase in the amount of phospholipids secreted (Figure 2.8). When type II cells were 
treated with similar concentrations of leptin, a peptide known to stimulate surfactant 
synthesis (Figure 2.6) (Torday and Rehan, 2002; Torday et al., 2002; Kirwin et al., 
2006), there was no effect on the rate of surfactant secretion from these cells. This 
contrasts with the finding that 50 ng.mL
-1
 heregulin-1β not only stimulates surfactant 
phospholipid synthesis but also enhances its secretion (Figures 2.5 and 2.8).    
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 It has been known for many years that β-agonists, operating through an 
interaction with the β-adrenergic receptor, markedly stimulate the secretion of surfactant 
phospholipids from type II cells (Dobbs and Mason, 1979; Brown and Longmore, 
1981). However, long-term use of β-agonists would need to be undertaken with caution 
as Lin et al. (2012) have recently shown that β-AR dysfunction can result from repeated 
clinical use of β-agonists in the treatment of asthma. A previous study from this 
laboratory has shown that 24-hour exposure of cultured fetal type II cells to heregulin-
1β resulted in a significant elevation in the level of the membrane-bound β-AR (Figure 
2.10). It is known that there are two major subtypes of β-adrenergic receptor, β1 and β2 
subtypes, and both have been shown to coexist in mammalian lung (Rugg et al., 1978). 
However, subsequent studies concluded that for fetal rat type II pneumocytes (Fabisiak 
et al., 1987), whole fetal rat lung (Whitsett et al., 1981) and fetal human lung (Davis et 
al., 1987) the predominant receptor is the β2 subtype. Irrespective of whether the type II 
cells were derived from male or female rat fetuses, exposure of these cells to heregulin-
1β resulted in a significant elevation in the level of membrane-bound β-adrenergic 
receptors (Figure 2.11). 
 As the response to β-agonists in stimulating surfactant phospholipid 
secretion from type II pneumocyte is known to be influenced by the level of β-AR it is 
of interest that media, which had been conditioned by fetal rat fibroblasts in the 
presence of dexamethasone, enhanced the β-AR activity to a greater extent if the cells 
were derived from female fetuses (Damas, 2010). This implies that female-derived 
fibroblasts produce a higher concentration of FPF than the equivalent cells derived from 
male fetal rats. As the heregulin-1β-induced activity of β-AR is virtually identical in 
cells derived from either sex, it suggests that this sex-linked difference is an attribute of 
lung fibroblasts, which is consistent with the previously published conclusions of 
Torday (1984) and Floros et al. (1987). 
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 In the current study the higher level of β-AR induced by heregulin-1β has 
been shown to result in a greater sensitivity of the type II cells to the β-adrenergic 
agonist (—)-isoproterenol. The finding that this agonist only slightly elevated the rate of 
surfactant phospholipid secretion from control type II cells is in contrast to an earlier 
study by Dobbs and Mason (1979). This may be explained by the fact that in their study 
culture medium was supplemented with 10% fetal calf serum, which is known to 
contain glucocorticoids, whereas in the current investigation steroids were removed by 
pre-treating the serum with charcoal. However, the response to (—)-isoproterenol was 
markedly increased when these cells were pre-treated with heregulin-1β (Figure 2.13). 
Although it has been previously shown that (—)-isoproterenol stimulates surfactant 
phospholipid secretion from epithelial cells (Dobbs and Mason, 1979; Ormond et al., 
2003; Abraham et al., 2004; Abrahama et al., 2004; Shi et al., 2011), this study, to my 
knowledge, is the first to show that the response to (—)-isoproterenol is amplified by 
pre-treatment with heregulin-1β. This heregulin-1β-induced elevation in the response to 
(—)-isoproterenol is also unaffected by the sex of the fetuses from which the type II 
cells were derived (Figure 2.14). Thus, neither the induction of β-AR by heregulin-1β 
nor its enhancement of β-agonist-induced secretion of surfactant phospholipids from 
fetal type II pneumocytes is affected by the sex of the donor animal.  
4.3 Effect of neuregulin-1β on β-AR gene expression  
 In the concentration range of 20-100 ng.mL
-1
, heregulin-1β had no impact 
on the level of expression of the β-AR gene in type II cells (Table 3.8; Figures. 3.21 and 
3.22), irrespective of whether the cells were exposed to heregulin-1β for 2, 4, 6 or 8 
hours. In contrast, if the type II cells were incubated with 50 nM dexamethasone for 6 
hours, there was a significantly greater level of expression of the β-AR gene (p < 0.05) 
when compared to the level of expression in control cultures. This verifies the findings 
of a number of investigators who have shown that exposure to glucocorticoids induces 
Chapter 4  General discussion 
131 
 
the β-AR gene in a variety of tissues (Collins et al., 1988; Hadcock and Malbon, 1988; 
Hadcock et al., 1989; Mak et al., 1995a; Dangel et al., 1996; Cornett et al., 1998), 
including the lung (Mak et al., 1995a; Cornett et al., 1998). When type II cells were 
exposed to the combined effects of heregulin-1β and dexamethasone for 6 hours, 
although the level of expression of the β-AR gene was slightly higher than that resulting 
from exposure to the steroid alone, this difference was not significant (Figure 3.21). In 
contrast, when the cells were simultaneously exposed to these two agents for a period of 
8 hours, there was a significantly higher level of β-AR gene expression than that which 
occurred in response to dexamethasone alone (Figure 3.22). This is the first time that 
dexamethasone and heregulin-1β have been shown to act synergistically in inducing the 
expression of the β-AR gene. This latter finding may provide an explanation for the 
previously mentioned observation of Damas (2010) that the elevation of β-AR activity 
was greater in type II cells exposed to FCM generated in the presence of dexamethasone 
than in cells directly exposed to the same concentration of the steroid (Figure 3.23). 
This could be explained if the preconditioning of the media by fibroblasts in the 
presence of dexamethasone leads not only to the carryover of the steroid, but also the 
generation of neuregulin-1β leading to a synergistic response. This further supports the 
hypothesis that neuregulin-1β is a component of FPF.   
 An anomalous result was the finding that exposure of type II cells to 
heregulin-1β for 24 hours enhanced the β-AR activity (Figure 2.11) despite this 
treatment having no effect on the level of β-AR gene expression at 2, 4 or 8 hours 
(Table 3.8, Figures 3.21 and 3.22). There are at least two possibilities that could account 
for this apparently contradictory observation. The up-regulation of β-AR activity by 
heregulin-1β may either be via a non-genomic mechanism or the expression of the β-AR 
gene could be transiently elevated in response to heregulin-1β at some time after 8 h 
exposure, leading to an enhanced activity of β-AR at 24 h. This latter suggestion is 
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consistent with the observations that dexamethasone induces a transient elevation in the 
β-AR mRNA at 2 hours but an enhanced β-AR activity 22 hours later in adult lung 
tissue from both humans (Mak et al., 1995a) and rats (McGraw et al., 1995).  
4.4 Suggestions for future work 
 The concentrations of both leptin and neuregulin-1β have been shown to be 
elevated in FCM in response to glucocorticoids. Moreover, each of these peptides 
stimulates surfactant phospholipid synthesis. As a consequence, it is difficult to know 
which of these peptides is the active component of FCM.  This issue could be clarified 
by using specific antibodies raised against leptin and neuregulin-1β.        
 The finding that neuregulin-1β concentration is elevated in FCM when the 
fibroblasts are exposed to glucocorticoids despite there being no effect of the steroid on 
neuregulin-1β gene expression appears to be anomalous. It has been suggested that the 
glucocorticoid-induced increase in the concentration of neuregulin-1β could be the 
result of enhanced cleavage of membrane-bound neuregulin precursors, enhanced 
mRNA or peptide stability or an elevation in the rate of mRNA translation. Additional 
experiments need to be conducted to ascertain which of these possibilities is the actual 
mechanism.  
 Since the β-AR receptor activity in type II cells was induced by a similar 
magnitude in cells derived from either male or female fetuses, it was assumed that the 
sex-linked difference in the response of these cells to glucocorticoids resided with the 
lung fibroblasts. It has previously been shown that exposure of lung fibroblasts to 
glucocorticoids elevated the level of neuregulin-1β in the surrounding media (Maker, 
2008), however, it should be noted that in that study the fibroblasts were derived from a 
mixture of both male and female fetuses. Given that many of the effects of 
glucocorticoids upon type II cells are suggested in this thesis as being mediated by 
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neuregulin-1β, it is important that the impact of glucocorticoids on the production 
and/or release of neuregulin-1β by lung fibroblasts be examined in cells derived from 
either male or female fetuses.   
 Although heregulin-1β has no effect on β-AR gene expression alone, it acts 
synergistically with dexamethasone to further enhance the level of expression of this 
gene when type II cells were exposed simultaneously to these two agents (Figure 3.22). 
In contrast, a previous preliminary investigation in this laboratory (Liong Ka Hang’s 
Honours thesis) showed that both heregulin-1β and dexamethasone induced an increase 
in the β-AR receptor activity whereas the response to a combination of both agents was 
not additive. Thus, the impact of glucocorticoids and heregulin-1β alone and in 
combination on the β-AR activity needs to be examined more extensively. 
 In the current study, both heregulin-1β and leptin were shown to increase 
the rate of surfactant phospholipid synthesis in cultured fetal rat type II pneumocytes 
whereas only the former peptide was shown to increase the rate of phospholipid 
secretion from these cells. Heregulin-1β was also shown to induce higher β-AR activity 
in type II cells, which promoted a greater secretory response to (—)-isoproterenol. 
Given that leptin and heregulin-1β exert their effects via different receptors (Kirwin et 
al., 2006; Zscheppang et al., 2007), it would be of interest to investigate whether leptin 
is also capable of inducing β-AR activity and whether or not the effects of these two 
peptides on surfactant phospholipid synthesis are additive or synergistic.   
4.5 Conclusions  
 In this study, a commercially available form of neuregulin-1β (heregulin-1β) 
has been shown to directly stimulate both the synthesis and secretion of surfactant 
phospholipids in cultured fetal rat type II pneumocytes. In addition, exposure of type II 
cells to this peptide enhanced the β-AR activity and, as a consequence, elevated the rate 
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of surfactant phospholipid secretion from these cells in response to the β-agonist        
(—)-isoproterenol. Although heregulin-1β had no effect on expression of the β-AR gene 
in type II cells exposed to the peptide alone, it was shown to act synergistically with 
dexamethasone in elevating the level of expression of the β-AR gene. All of these 
effects of neuregulin-1β, together with those of leptin and glucocorticoids, are 
summarized in Figure 4.1. The results for neuregulin-1β reported in this thesis therefore, 
not only support, but notably extend the proposal of Dammann et al. (2003) that 
neuregulin-1β plays an essential role in the differentiation and maturation of the lung in 
the later stages of gestation.    
 In order to understand the mechanism(s) by which neuregulin-1β exerts its 
numerous effects it needs to be recognized that, in both mice and rats, that the responses 
of lung cells to this peptide are mediated via ErbB receptors (Dammann et al., 2006; 
Zscheppang et al., 2006; Zscheppang et al., 2007). Using a small interfering RNA 
(siRNA), which targeted the ErbB4 gene and silenced ErbB4 receptor activity in 
cultured 19-day fetal type II pneumocytes, Zscheppang et al. (2007) demonstrated that 
the resulting downregulation of the ErbB4 receptor caused a diminished rate of 
surfactant phospholipid synthesis. Their conclusion that the response of these cells to 
neuregulin-1β is mediated through ErbB4 receptor activation was supported by the 
observations that exposure of both fetal and adult rat lung epithelial cells to 
neuregulin-1β resulted in increased phosphorylation of the ErbB4 receptor (Liu et al., 
2007; Liu et al., 2009).    
 Since neuregulin-1β (in this study heregulin-1β) has been shown to have a 
range of stimulatory effects on surfactant phospholipid synthesis and secretion, it could 
potentially be used as an alternative or supplementary treatment for overcoming the 
injurious effects of  NRDS,  which are common  in  prematurely delivered  infants.  The 
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 Figure 4.1 Effects of glucocorticoids and neuregulin-1β on surfactant production 
by fetal type II pneumocytes. 
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current regime for preventing the development of NRDS is the administration of 
glucocorticoids to pregnant women showing signs of imminent premature delivery 
(Liggins and Howie, 1972; Newnham and Moss, 2001). However, this procedure has 
two major drawbacks: (1) the stimulation of lung maturation by glucocorticoids is slow 
because it is an indirect effect and involves the production of FPF by lung fibroblasts 
(Smith, 1979; Post et al., 1986; Smith and Post, 1989), and (2) male infants do not 
respond particularly well to this treatment (Torday et al., 1981; Torday, 1984). In this 
context, neuregulin-1β administration would provide an improved method of treatment 
as it would act more rapidly through its direct action on the type II cells and the 
response to this peptide is the same in cells derived from both male and female fetuses. 
As the response times of type II cells to glucocorticoids and neuregulin-1β are 
dramatically different, it is suggested that a more effective treatment might involve the 
simultaneous administration of these two agents as it would provide a longer duration of 
response than either agent alone. However, it needs to be borne in mind that 
neuregulin-1β operates via ErbB receptors and that overexpression of members of this 
receptor family have been linked to both non-small cell lung and breast carcinomas 
(Brabender et al., 2001; Yang et al., 2006; Yang et al., 2008; Pan et al., 2011). 
Therefore, the concentration of neuregulin-1β used in the treatment of NRDS, as 
proposed above, would need to be carefully evaluated to ensure that none of these 
deleterious side effects are simultaneously activated. Such an approach would be 
consistent with the recommendation of Torday and Rehan (2007) that any 
physiologically or developmentally relevant interventions used in the treatment of lung 
diseases should be carefully selected. 
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